[go: up one dir, main page]

WO2021129708A1 - 药物传送结构、药物传送装置及药柜 - Google Patents

药物传送结构、药物传送装置及药柜 Download PDF

Info

Publication number
WO2021129708A1
WO2021129708A1 PCT/CN2020/138847 CN2020138847W WO2021129708A1 WO 2021129708 A1 WO2021129708 A1 WO 2021129708A1 CN 2020138847 W CN2020138847 W CN 2020138847W WO 2021129708 A1 WO2021129708 A1 WO 2021129708A1
Authority
WO
WIPO (PCT)
Prior art keywords
medicine
drug delivery
clamping
driving module
delivery structure
Prior art date
Application number
PCT/CN2020/138847
Other languages
English (en)
French (fr)
Inventor
黎超强
植赐波
张晓�
林文东
Original Assignee
深圳诺博医疗科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 深圳诺博医疗科技有限公司 filed Critical 深圳诺博医疗科技有限公司
Publication of WO2021129708A1 publication Critical patent/WO2021129708A1/zh

Links

Images

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65G—TRANSPORT OR STORAGE DEVICES, e.g. CONVEYORS FOR LOADING OR TIPPING, SHOP CONVEYOR SYSTEMS OR PNEUMATIC TUBE CONVEYORS
    • B65G43/00—Control devices, e.g. for safety, warning or fault-correcting
    • B65G43/08—Control devices operated by article or material being fed, conveyed or discharged
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65G—TRANSPORT OR STORAGE DEVICES, e.g. CONVEYORS FOR LOADING OR TIPPING, SHOP CONVEYOR SYSTEMS OR PNEUMATIC TUBE CONVEYORS
    • B65G15/00—Conveyors having endless load-conveying surfaces, i.e. belts and like continuous members, to which tractive effort is transmitted by means other than endless driving elements of similar configuration
    • B65G15/30—Belts or like endless load-carriers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65G—TRANSPORT OR STORAGE DEVICES, e.g. CONVEYORS FOR LOADING OR TIPPING, SHOP CONVEYOR SYSTEMS OR PNEUMATIC TUBE CONVEYORS
    • B65G17/00—Conveyors having an endless traction element, e.g. a chain, transmitting movement to a continuous or substantially-continuous load-carrying surface or to a series of individual load-carriers; Endless-chain conveyors in which the chains form the load-carrying surface
    • B65G17/06—Conveyors having an endless traction element, e.g. a chain, transmitting movement to a continuous or substantially-continuous load-carrying surface or to a series of individual load-carriers; Endless-chain conveyors in which the chains form the load-carrying surface having a load-carrying surface formed by a series of interconnected, e.g. longitudinal, links, plates, or platforms
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65G—TRANSPORT OR STORAGE DEVICES, e.g. CONVEYORS FOR LOADING OR TIPPING, SHOP CONVEYOR SYSTEMS OR PNEUMATIC TUBE CONVEYORS
    • B65G17/00—Conveyors having an endless traction element, e.g. a chain, transmitting movement to a continuous or substantially-continuous load-carrying surface or to a series of individual load-carriers; Endless-chain conveyors in which the chains form the load-carrying surface
    • B65G17/12—Conveyors having an endless traction element, e.g. a chain, transmitting movement to a continuous or substantially-continuous load-carrying surface or to a series of individual load-carriers; Endless-chain conveyors in which the chains form the load-carrying surface comprising a series of individual load-carriers fixed, or normally fixed, relative to traction element
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65G—TRANSPORT OR STORAGE DEVICES, e.g. CONVEYORS FOR LOADING OR TIPPING, SHOP CONVEYOR SYSTEMS OR PNEUMATIC TUBE CONVEYORS
    • B65G17/00—Conveyors having an endless traction element, e.g. a chain, transmitting movement to a continuous or substantially-continuous load-carrying surface or to a series of individual load-carriers; Endless-chain conveyors in which the chains form the load-carrying surface
    • B65G17/12—Conveyors having an endless traction element, e.g. a chain, transmitting movement to a continuous or substantially-continuous load-carrying surface or to a series of individual load-carriers; Endless-chain conveyors in which the chains form the load-carrying surface comprising a series of individual load-carriers fixed, or normally fixed, relative to traction element
    • B65G17/123—Conveyors having an endless traction element, e.g. a chain, transmitting movement to a continuous or substantially-continuous load-carrying surface or to a series of individual load-carriers; Endless-chain conveyors in which the chains form the load-carrying surface comprising a series of individual load-carriers fixed, or normally fixed, relative to traction element arranged to keep the load-carriers horizontally during at least a part of the conveyor run
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65G—TRANSPORT OR STORAGE DEVICES, e.g. CONVEYORS FOR LOADING OR TIPPING, SHOP CONVEYOR SYSTEMS OR PNEUMATIC TUBE CONVEYORS
    • B65G17/00—Conveyors having an endless traction element, e.g. a chain, transmitting movement to a continuous or substantially-continuous load-carrying surface or to a series of individual load-carriers; Endless-chain conveyors in which the chains form the load-carrying surface
    • B65G17/30—Details; Auxiliary devices
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65G—TRANSPORT OR STORAGE DEVICES, e.g. CONVEYORS FOR LOADING OR TIPPING, SHOP CONVEYOR SYSTEMS OR PNEUMATIC TUBE CONVEYORS
    • B65G17/00—Conveyors having an endless traction element, e.g. a chain, transmitting movement to a continuous or substantially-continuous load-carrying surface or to a series of individual load-carriers; Endless-chain conveyors in which the chains form the load-carrying surface
    • B65G17/30—Details; Auxiliary devices
    • B65G17/32—Individual load-carriers
    • B65G17/34—Individual load-carriers having flat surfaces, e.g. platforms, grids, forks
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65G—TRANSPORT OR STORAGE DEVICES, e.g. CONVEYORS FOR LOADING OR TIPPING, SHOP CONVEYOR SYSTEMS OR PNEUMATIC TUBE CONVEYORS
    • B65G23/00—Driving gear for endless conveyors; Belt- or chain-tensioning arrangements
    • B65G23/02—Belt- or chain-engaging elements
    • B65G23/04—Drums, rollers, or wheels
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65G—TRANSPORT OR STORAGE DEVICES, e.g. CONVEYORS FOR LOADING OR TIPPING, SHOP CONVEYOR SYSTEMS OR PNEUMATIC TUBE CONVEYORS
    • B65G23/00—Driving gear for endless conveyors; Belt- or chain-tensioning arrangements
    • B65G23/02—Belt- or chain-engaging elements
    • B65G23/04—Drums, rollers, or wheels
    • B65G23/06—Drums, rollers, or wheels with projections engaging abutments on belts or chains, e.g. sprocket wheels
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65G—TRANSPORT OR STORAGE DEVICES, e.g. CONVEYORS FOR LOADING OR TIPPING, SHOP CONVEYOR SYSTEMS OR PNEUMATIC TUBE CONVEYORS
    • B65G23/00—Driving gear for endless conveyors; Belt- or chain-tensioning arrangements
    • B65G23/22—Arrangements or mountings of driving motors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65G—TRANSPORT OR STORAGE DEVICES, e.g. CONVEYORS FOR LOADING OR TIPPING, SHOP CONVEYOR SYSTEMS OR PNEUMATIC TUBE CONVEYORS
    • B65G2201/00—Indexing codes relating to handling devices, e.g. conveyors, characterised by the type of product or load being conveyed or handled
    • B65G2201/02—Articles
    • B65G2201/0235—Containers
    • B65G2201/0244—Bottles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65G—TRANSPORT OR STORAGE DEVICES, e.g. CONVEYORS FOR LOADING OR TIPPING, SHOP CONVEYOR SYSTEMS OR PNEUMATIC TUBE CONVEYORS
    • B65G2203/00—Indexing code relating to control or detection of the articles or the load carriers during conveying
    • B65G2203/02—Control or detection
    • B65G2203/0208—Control or detection relating to the transported articles
    • B65G2203/0258—Weight of the article
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65G—TRANSPORT OR STORAGE DEVICES, e.g. CONVEYORS FOR LOADING OR TIPPING, SHOP CONVEYOR SYSTEMS OR PNEUMATIC TUBE CONVEYORS
    • B65G2203/00—Indexing code relating to control or detection of the articles or the load carriers during conveying
    • B65G2203/04—Detection means
    • B65G2203/042—Sensors
    • B65G2203/044—Optical

Definitions

  • This application relates to the field of medicine delivery technology, and in particular to a medicine delivery structure, a medicine delivery device and a medicine cabinet.
  • a drug delivery structure including a fixed column, a plurality of first connecting pieces and a plurality of second connecting pieces;
  • the first connecting member is substantially L-shaped, and two long sides of the short bottom surface of the first connecting member are respectively provided with first connecting posts;
  • the second connecting piece is substantially L-shaped, and two long sides of the short bottom surface of the second connecting piece are respectively provided with second connecting posts corresponding to the first connecting posts;
  • a medicine delivery device comprising the above medicine delivery structure, a source driving module for providing driving force, a main driving module and a housing;
  • the driving force of the source driving module is transmitted to the main driving module; the main driving module is used to drive the drug delivery structure to rotate around the main driving module; when the drug delivery structure rotates, it drives the The medicine movement in the medicine delivery structure; the housing is used for accommodating the source drive module, the main drive module and the medicine delivery structure; the housing is also provided with a medicine outlet.
  • a medicine cabinet includes the above-mentioned medicine delivery mechanism.
  • the above-mentioned drug delivery structure is buckled in pairs by the first connecting piece and the second connecting piece, and then fixed by the fixing post. Therefore, the two short bottom surfaces of the first connecting piece and the second connecting piece are connected to form a receiving space with their two long bottom surfaces. , Used to contain drugs. During the rotation of the drug delivery structure, the drug in the containing space can be driven to move, thereby realizing drug delivery.
  • a storage space for accommodating medicines is formed between each of the first connecting pieces and the second connecting pieces which are arranged oppositely. The storage space is convenient for storing a single medicine, thereby realizing the management of a single medicine.
  • the above-mentioned drug delivery device provides driving force through the source drive module to rotate the main drive module, and then the main drive module drives the movement of the drug delivery structure.
  • the drug placed in the drug delivery structure can follow the movement of the drug delivery structure, and the housing is used to house the source drive module.
  • the main driving module and the medicine delivery structure can prevent the medicine from being scattered during the delivery process, and then realize the medicine delivery. Compared with the traditional drug delivery device, the components are reduced, thereby reducing the product cost.
  • Figure 1 is a schematic diagram of a drug delivery structure provided by one of the embodiments of the application.
  • Figure 2 is a schematic view of the structure of the first connecting piece
  • Figure 3 is a schematic view of the structure of the second connecting piece
  • Figure 4 is a schematic view of the structure of the third connecting piece
  • Figure 5 is a block diagram of the drug delivery device
  • Figure 6 is a schematic diagram of the structure of the main drive module, transmission module, and source drive module;
  • Figure 7 is a schematic diagram of the structure of the slave drive module
  • Figure 8 is one of the structural schematic diagrams of the drug delivery device
  • Figure 9 is the second structural diagram of the drug delivery device
  • FIG. 10 is a three-dimensional schematic diagram of the drug delivery device provided by one of the embodiments of the application after the top cover is hidden;
  • Fig. 11 is an exploded schematic diagram of the drug delivery device in Fig. 10 after the top cover is hidden;
  • Fig. 12 is a perspective schematic view of the receiving groove in one direction in Fig. 10;
  • FIG. 13 is a three-dimensional schematic view of the receiving slot in FIG. 10 in another direction;
  • Figure 14 is a perspective schematic view of the receiving slot in Figure 10 in another direction
  • Fig. 15 is a perspective schematic view of the first connecting member in one direction in Fig. 10;
  • Fig. 16 is a perspective schematic view of the second connecting member in one direction in Fig. 10;
  • Figure 17 is a three-dimensional schematic diagram of the limiting component in Figure 10 in one direction;
  • Fig. 18 is a perspective schematic view of the limiting component in Fig. 10 in another direction;
  • Fig. 19 is a three-dimensional schematic diagram of the limiting component in Fig. 10 in another direction;
  • FIG. 20 is a three-dimensional schematic diagram of a drug delivery mechanism provided by one of the embodiments of this application.
  • Figure 21 is a partial exploded schematic view of the base in Figure 20;
  • Fig. 22 is a three-dimensional schematic diagram of the base in Fig. 20;
  • Figure 23 is a three-dimensional schematic diagram of the clamping member in Figure 20;
  • Fig. 24 is a schematic cross-sectional view taken along line A-A of the drug delivery mechanism in Fig. 20;
  • FIG. 25 is a three-dimensional schematic diagram of a drug delivery mechanism provided by one of the embodiments of this application.
  • Figure 26 is a schematic cross-sectional view of one direction of the drug delivery structure in Figure 25;
  • Figure 27 is an exploded schematic view of the drug delivery structure in Figure 25;
  • Figure 28 is an exploded schematic view of the drug delivery device in Figure 25;
  • Fig. 29 is a perspective schematic view of the drug delivery device in Fig. 25 in one direction after the housing is hidden;
  • Fig. 30 is a perspective schematic view of the drug delivery device in Fig. 25 in another direction after the housing is hidden;
  • FIG. 31 is an exploded schematic diagram of a medicine delivery mechanism according to one embodiment of the application.
  • Fig. 32 is a schematic diagram of the connection of the front end plate, the gate and the drive assembly in Fig. 31;
  • Fig. 33 is an exploded schematic diagram of the gate and drive assembly in Fig. 31;
  • Figure 34 is a three-dimensional schematic diagram of the gate in Figure 31;
  • 35 is a three-dimensional schematic diagram of a medicine cabinet provided by one of the embodiments of the application.
  • Figure 36 is a perspective schematic view of the drawer unit in Figure 35;
  • Figure 37 is a perspective schematic view of the drawer unit of Figure 36 with the drawer frame and the drug delivery mechanism group hidden;
  • Fig. 38 is a perspective schematic view of the conveying mechanism in Fig. 36.
  • a drug delivery structure 200 includes a fixed post (not labeled), a plurality of first connecting members 10 and a plurality of second connecting members 20;
  • the first connecting member 10 is substantially L-shaped, and two long sides of the short bottom surface of the first connecting member 10 are respectively provided with first connecting posts 103;
  • the second connecting member 20 is substantially L-shaped, and two long sides of the short bottom surface of the second connecting member 20 are respectively provided with second connecting posts corresponding to the first connecting posts 103;
  • first connecting posts 103 and a plurality of the second connecting posts are buckled in pairs, they are then fixedly connected by the fixing posts (not labeled) to form the drug delivery structure 200.
  • the first connecting member 10 includes a first long bottom surface 101, a first short bottom surface 102 and a first connecting column 103.
  • the first long bottom surface 101 and the first short bottom surface 102 are arranged substantially perpendicularly, the first long bottom surface 101 and the first short bottom surface 102 are intersected to form a first connecting pillar 103, and the other side of the first short bottom surface 102
  • the first connecting pillars 103 are arranged in parallel. That is, two parallel first connecting pillars 103 are provided on two opposite long sides of the first short bottom surface 102.
  • the second connecting member 20 includes a second long bottom surface 201, a second short bottom surface 202 and a second connecting column 203.
  • the second long bottom surface 201 and the second short bottom surface 202 are arranged substantially perpendicularly, the second long bottom surface 201 and the second short bottom surface 202 are intersected on the side formed by the second connecting column 203, and the second short bottom surface 202 is on the other side
  • the second connecting pillars 203 are arranged in parallel. That is, two parallel second connecting posts 203 are provided on two opposite long sides of the second short bottom surface 202.
  • the first long bottom surface 101 of the first connecting member 10 is in close contact with the second long bottom surface 201 of the second connecting member 20, and the first short bottom surface 102 of the first connecting member 10 is connected to the second short bottom surface 202 of the second connecting member 20. Abut. Therefore, the first connecting column 103 at the edge of the first long bottom surface 101 can be buckled with the second connecting column at the edge of the second long bottom surface 201, and the first connecting column 103 at the edge of the first short bottom surface 102 can be connected to the edge of the second short bottom surface 202.
  • the second connecting column is buckled.
  • the first connecting column 103 and the second connecting column are then fixed by a fixing column (not labeled), so as to realize a fixed connection between the first connecting piece 10 and the second connecting piece 20. After a plurality of first connecting members 10 and second connecting members 20 are buckled, the drug delivery structure 200 can be formed.
  • first connecting member 10 and the second connecting member 20 are alternately arranged, and the adjacent first connecting member 10 and the second connecting member 20 are buckled with the second connecting post 223 through the first connecting post 103, and then It is fixedly connected by a fixing column to form the above-mentioned annular drug delivery structure 200 and enclose an annular space (the waist-shaped space shown in FIG. 1). It is worth noting that between the two adjacent first connecting members 10 and the second connecting member 20 located between the two first connecting members 10, the second short bottom surface 202 of the second connecting member 20 is connected to a first connecting member.
  • the first short bottom surface 102 of the member 10 is opposite to each other, then the first connecting member 10 and the second connecting member 20 arranged opposite to form a storage space for accommodating medicines; at the same time, the second short bottom surface of the second connecting member 20
  • the bottom surface 202 and the first short bottom surface 102 of the other first connecting member 10 are disposed opposite to each other, and the first long bottom surface 101 and the second long bottom surface 201 are disposed away from the annular space, and are connected to form the above-mentioned drug delivery structure 200 according to this rule.
  • the first connecting column 103 includes a first circular connecting column 1031 and a first semicircular connecting column 1032.
  • the first circular connecting pillars 1031 are arranged at the edges of the two long sides of the first short bottom surface 102
  • the first semicircular connecting pillars 1032 are arranged at the middle positions of the two long sides of the first short bottom surface 102.
  • the second connecting column includes a second circular connecting column 2031 and a second semicircular connecting column 2032.
  • the second circular connecting column 2031 and the second semicircular connecting column 2032 are arranged at positions corresponding to the first circular connecting column 1031 and the first circular connecting column 1031 and the second circular connecting column 2032.
  • the positions of the semicircular connecting pillars 1032 are complementary, that is, the first connecting pillar 103 can be just buckled with the second connecting pillar.
  • the first circular connecting column 1031, the first semicircular connecting column 1032, the second circular connecting column 2031, and the second semicircular connecting column 2032 are all hollow, which enables a fixed column (not labeled) to pass through the first A circular connecting column 1031, a first semicircular connecting column 1032, a second circular connecting column 2031, a second semicircular connecting column 2032, thereby realizing the fixation of the first connecting member 10 and the second connecting member 20.
  • the length of the drug delivery structure 200 can be set according to the actual needs of the user. Therefore, the number of the first connecting member 10 and the second connecting member 20 can be freely set according to the actual demand of the user.
  • the radial cross section of the drug delivery structure 200 is generally elliptical. Therefore, at the positions of the two top ends of the ellipse, the first connecting member 10 and the second connecting member 20 will open due to tension. It is worth mentioning that in some other embodiments, the first connecting member and the second connecting member are of an integrated structure, and there is only one partition on both sides of the containing space, and the two adjacent end regions of the drug delivery structure The partitions will open outwards, resulting in an overall increase in the containing space, resulting in an increase in the space for free movement of medicines; at the same time, the part of the medicine conveying structure facing the annular space will be greatly bent and deformed.
  • the accommodating space is surrounded by the first connecting member 10 and the second connecting member 20 that are opposite to each other.
  • Each accommodating space has two partitions on both sides (that is, the first long bottom surface and the second long bottom surface). ), a fan-shaped space is formed between two adjacent storage spaces, and the fan-shaped space can occupy a part of the space, thereby reducing the overall opening angle of the storage space, that is, the free movement space of the medicine is also small.
  • the first connecting piece 10 and the second connecting piece 20 disposed opposite to each other are inclined to form an included angle after being opened, so the magnitude of deformation of each connecting piece is smaller, and the overall working life of the drug delivery structure 200 is longer.
  • the shape of the drug delivery structure 200 may also be a circle, a rounded rectangle, etc., which are not limited here.
  • An edge of the first long bottom surface 101 away from the first short bottom surface 102 is provided with a U-shaped notch.
  • An edge of the second long bottom surface 201 away from the second short bottom surface 202 is provided with a U-shaped notch that is completely consistent with the U-shaped notch of the first long bottom surface 101.
  • gaskets can be arranged along all U-shaped cuts, which can reduce the containing space formed by the first connector 10 and the second connector 20.
  • the gasket is eliminated.
  • the drug delivery structure 200 further includes a third connecting member 30.
  • the two long sides of the third connecting member 30 are respectively provided with the first connecting column 103 and the second connecting column 203, so The first connecting post 103 of the third connecting piece 30 is buckled with the second connecting post 203 of the second connecting piece 20 and then fixedly connected by the fixing post (not labeled).
  • the two connecting posts are buckled with the first connecting post 103 of the first connecting member 10 and then fixedly connected by the fixing post (not labeled).
  • the third connecting member 30 is used to connect the first connecting member 10 and the second connecting member 20 that are arranged oppositely; that is, the first connecting member 10, the third connecting member 30, and the second connecting member 20 are alternately arranged in order to expand the accommodation
  • the overall volume of the space facilitates the management of larger volumes of medicines.
  • the arrangement of the third connecting member 30 is convenient for the manufacturer to realize the two types by selectively using or not using the third connecting member 30 without having to change the size specifications of the first connecting member 10 and the second connecting member 20. Specification of the above-mentioned drug delivery structure and production of related devices.
  • the third connecting member 30 is in the shape of a sheet.
  • the third connecting member 30 includes a third long bottom surface 301 and a first connecting column 103 and a second connecting column 203 disposed on two opposite long sides of the third long bottom surface 301.
  • the third connecting member 30 is provided to widen the accommodating space formed by the first connecting member 10 and the second connecting member 20, so as to facilitate the control of a larger volume of medicines.
  • the first connecting pillar 103 includes a first circular connecting pillar 1031 and a first semicircular connecting pillar 1032 that are intermittently arranged, and the first circular connecting pillar 1031 and the first semicircular connecting pillar 1031 are intermittently arranged.
  • the second connecting column 1032 is on one axis; the second connecting column includes a second circular connecting column 2031 and a second semicircular connecting column 2032 that are intermittently arranged.
  • the second circular connecting column 2031 and the second The semicircular connecting column 2032 is on an axis.
  • the first connecting column 103 may include only one first circular connecting column 1031, and the second connecting column may also include only one second circular connecting column 2031. That is, the first connecting column 103 and the second connecting column can be fixed by a fixing column (not labeled).
  • the radial diameters of the first circular connecting column 1031, the first semicircular connecting column 1032, the second circular connecting column 2031, and the second semicircular connecting column 2032 are equal.
  • the widths of the first short bottom surface 102, the second short bottom surface 202, and the third long bottom surface 301 are equal.
  • the drug delivery structure 200 further includes a light blocking sheet 204 which is vertically arranged on the short bottom surface of the first connecting member 10 or the short bottom surface of the second connecting member 20.
  • the light blocking sheet 204 is disposed on the second short bottom surface 202 of the second connecting member 20 and is perpendicular to the second short bottom surface 202 of the second connecting member 20.
  • the light blocking sheet 204 is used to block the light sent by the laser counter, and counts once every time it blocks.
  • the two short bottom surfaces of the first connecting member 10 and the second connecting member 20 After being connected, the two long bottom surfaces form a containment space for containing medicines.
  • the containment formed by two adjacent first connecting pieces 10 and second connecting pieces 20 only one medicine can be placed.
  • the medicine in the containing space can be driven to move, thereby realizing the medicine delivery.
  • the third connecting piece 30 is added to expand the containing space, that is, the first connecting piece 10, the second connecting piece 20, and the third connecting piece 30 jointly form the containing space for placing the medicine.
  • the thickness of the first connecting member 10, the second connecting member 20, and the third connecting member 30 and the width of each bottom surface can be adjusted according to the size of the medicine to be delivered.
  • the volume of the medicine is small, only the first connecting piece 10 and the second connecting piece 20 are used to form a containing space for placing the medicine. If the accommodating space formed can accommodate two medicines at the same time, it is necessary to provide gaskets at the openings of the first connector 10 and the second connector 20, thereby reducing the accommodating space and preventing users from placing two medicines in one accommodating space at the same time in.
  • FIG. 5 it is a block diagram of the drug delivery device.
  • a medicine delivery device includes the above medicine delivery structure 200, a source driving module 502 for providing driving force, a main driving module 503, and a housing 501;
  • the driving force of the source driving module 502 is transmitted to the main driving module 503; the main driving module 503 is used to drive the medicine delivery structure 200 to rotate around the main driving module 503; the medicine delivery structure 200 rotates At this time, the medicine placed in the medicine delivery structure 200 is driven to move; the housing 501 is used to house the source drive module 502, the main drive module 503, and the medicine delivery structure 200; the housing 501 is also provided with There are drug exports.
  • the source drive module 502 includes a motor 5021 and a first rotating wheel 5022.
  • the motor 5021 is fixedly connected to the first rotating wheel 5022. When the motor 5021 rotates, the first rotating wheel is driven. The wheel 5022 rotates.
  • the rotating shaft of the motor 5021 is fixedly connected with the axis of the first rotating wheel 5022, and during the rotation of the motor 5021, the first rotating wheel 5022 is driven to rotate. Therefore, the first runner 5022 drives the other runners connected to it to rotate through gear transmission.
  • the main driving module 503 includes a third rotating wheel 5032, a first rotating shaft 5033, and a first sprocket 5031.
  • the first rotating shaft 5033 passes through the first sprocket 5031, one free end of the first rotating shaft 5033 is fixedly connected to the axis of the third rotating wheel 5032, and the other free end is received in the In the housing 501; when the third rotating wheel 5032 rotates, the first rotating shaft 5033 is driven to rotate, thereby driving the first sprocket 5031 to rotate.
  • the first runner 5022 and the third runner 5032 are directly toothed, and when the first runner 5022 rotates, the third runner 5032 can be driven to rotate.
  • the axis of the third rotating wheel 5032 is fixedly connected to the first rotating shaft 5033, and at the same time, the first rotating shaft 5033 is fixedly connected to the first sprocket 5031. Therefore, when the third rotating wheel 5032 rotates, it will drive the first rotating shaft 5033 and the first sprocket 5031 to rotate at the same time.
  • the tooth grooves and tooth arrangement of the first sprocket 5031 are consistent with the first connecting column 103, the first short bottom surface 102, the second connecting column, and the second short bottom surface 202 of the drug delivery structure 200. That is, the first connecting post 103 and the second connecting post 203 fall into the tooth groove of the first sprocket 5031, and the gear teeth of the first sprocket 5031 fall into the first short bottom surface 102 and the second short bottom surface 202. If the third connecting member 30 is added to the medicine delivery structure 200. The gear teeth of the first sprocket 5031 will fall into the first short bottom surface 102, the second short bottom surface 202, and the third long bottom surface 301, respectively.
  • the first rotating shaft 5033 is trimmed in the radial direction, so that there is no relative displacement between the first rotating shaft 5033 and the first sprocket 5031.
  • the drug delivery device further includes a transmission module 505 respectively connecting the source driving module 502 and the active driving module; the transmission module 505 is used to transmit the driving force of the source driving module 502 to all
  • the main driving module 503 is described.
  • the transmission module 505 includes a second runner, which is connected to the source driving module 502, and when the source driving module 502 rotates, the second runner is driven to rotate.
  • the medication delivery device further includes a slave driving module 506 which is arranged opposite to the master driving module 503 so that the medication delivery structure 200 rotates around the master driving module 503 and the slave driving module 506 at the same time.
  • the slave driving module 506 includes a second rotating shaft 5063 and a second sprocket 5061.
  • the second rotating shaft 5063 passes through the second sprocket 5061, and a free end of the second rotating shaft 5063 is housed in the housing 501; when the first sprocket 5031 rotates, the first sprocket 5031 drives the first sprocket.
  • the shaft 5033 rotates.
  • the slave driving module 506 further includes a sleeve 5062, a spring member 5064, and a fixing member 5065.
  • the sleeve 5062 is respectively sleeved on the two free ends of the second rotating shaft 5063, and the free end of the sleeve 5062 extending in the radial direction is connected to the fixing member 5065.
  • the spring member 5064 is sleeved on the free end of the sleeve 5062. During the rotation from the driving module 506, when a tensile force is generated in the radial direction, the sleeve 5062 and the spring member 5064 are deformed to offset the tensile force.
  • the medicine delivery structure 200 can be tightly rotated around the main driving module 503 and the slave driving module 506.
  • the source driving module 502, the transmission module 505 and the main driving module 503 are sequentially arranged in the hollow position formed by the medicine conveying structure 200, wherein the first sprocket 5031 of the main driving module 503 is attached to the medicine conveying structure 200. Since the arrangement of the tooth grooves and gear teeth of the first connection is completely consistent with the first connection post 103, the second connection post, the first short bottom surface 102 and the second short bottom surface 202 of the drug delivery structure 200, the main drive module When 503 rotates, the medicine delivery structure 200 can be driven to rotate with the main driving module 503.
  • a slave driving module 506 is provided at the other end of the medicine delivery structure 200.
  • the second sprocket 5061 of the slave drive module 506 is completely identical in structure to the first sprocket 5031. Therefore, the second sprocket 5061 can also drive the medicine delivery structure 200 to rotate with the main driving module 503.
  • the housing 501 includes a receiving slot and a top cover; the receiving slot is used to receive the source drive module 502, the main drive module 503, and the drug delivery structure 200, and the receiving slot is also provided with the drug outlet ; The opening side of the receiving slot is movably connected with the top cover.
  • the drug delivery device also includes a first bottom cover (not shown) and a second bottom cover (not shown), the first bottom cover (not shown) and the second bottom cover (not shown) respectively cover When the drug delivery structure 200 rotates around the main driving module 503, two sides are formed.
  • the source driving module 502 provides driving force to drive the transmission module 505 so that the transmission module 505 transmits the driving force to the main driving module 503. Therefore, the main driving module 503 can drive the drug delivery structure 200 to the main driving module 503 Rotate.
  • a slave driving module 506 is provided, so that the medicine delivery structure 200 can rotate more stably with the master driving module 503 and the slave driving module 506.
  • the housing 501 houses the medicine delivery structure 200
  • the source drive module 502, the transmission module 505, the master drive module 503, and the slave drive module 506, the medicine is placed in the accommodating space of the medicine delivery structure 200, and only one can be stored in each accommodating space. Drugs.
  • the medicine delivery structure 200 will be driven to move together.
  • the medicine delivery structure 200 is controlled to move to a specific position, and the medicine is moved to the opening of the housing 501, so that the medicine can automatically fall. , Realize the function of single withdrawal of medicine.
  • the transmission module and/or the slave driving module 506 may not be used. It can also realize the function of single drug control.
  • a single drug can be controlled.
  • a medicine is placed in each storage space of the medicine transmission structure 200, and the size of the storage space can be adjusted according to the volume of the medicine, so that it can just hold a single medicine.
  • the structure of the drug delivery device is simpler, and the storage space can be adjusted according to the volume of the controlled drug, without changing the main structure, adding or reducing gaskets on the original basis. Compatible with various specifications of medicines.
  • the above-mentioned drug delivery device provides driving force through the source drive module 502 to rotate the main drive module 503, and then the main drive module 503 drives the drug delivery structure 200 to move, and the drugs placed in the drug delivery structure 200 can follow the drug delivery structure 200 to move.
  • the housing 501 is used to house the source driving module 502, the main driving module 503, and the medicine delivery structure 200, which can prevent the medicine from being scattered during the delivery process, thereby realizing the medicine delivery. Compared with the traditional drug delivery device, the components are reduced, thereby reducing the product cost.
  • the source drive module 502 is indirectly through a transmission module 505 and the main drive module 503.
  • the drug delivery structure 200 is driven to move, but the present application is not limited to this; in other embodiments of the present application, it may also include only a source driving module.
  • the source drive module includes a motor and the above-mentioned first sprocket, and the first sprocket is installed at the output end of the motor, which can also implement the above-mentioned solution.
  • the above-mentioned drug delivery device further includes a limiting component 40 for constricting the above-mentioned containing space.
  • the above-mentioned drug delivery mechanism 1000 encloses an annular space; the limiting component 40 is installed on the inner wall of the receiving groove 5011 and extends around the annular space in a non-closed C shape, and the limiting component 40 is formed between the two non-closed ends An opening facing the above-mentioned drug outlet.
  • both sides of the first long bottom surface 101 and the second long bottom surface 201 away from the annular space are provided with at least part of the avoidance cutouts for accommodating the above-mentioned limiting component 40, so that during the movement of the drug delivery structure 200, Avoid interference between the first connecting member 10 and the limiting component 40, and avoiding interference between the second connecting member 20 and the limiting component 40.
  • the setting of the limiting component 40 can limit the size of the above-mentioned receiving space, so that the medicine delivery device is suitable for storing small-volume medicines. Specifically, please refer to FIGS.
  • the above-mentioned housing 501 includes a receiving groove 5011 and a top cover 5012.
  • the receiving groove 5011 specifically includes a bottom plate 50111 and an annular plate 50112.
  • the bottom plate 50111 is in the shape of a flat plate, and the bottom plate 50111 is connected to one end of the annular plate 50112.
  • the bottom plate 50111 and the ring plate 50112 are enclosed to form a receiving groove, and the receiving groove has an opening on the side facing away from the bottom plate 50111; the top cover 5012 covers the opening.
  • the limiting component 40 is received in the above-mentioned receiving slot.
  • the annular plate 50112 includes a first arc-shaped portion 501121, a second arc-shaped portion 501122, The first flat part 501123 and the second flat part 501124.
  • the first arc-shaped portion 501121 and the second arc-shaped portion 501122 are disposed opposite to each other, the first flat portion 501123 and the second flat portion 501124 are disposed oppositely, the first arc portion 501121, the first flat portion 501123, the second arc portion 501122 and The second flat portion 501124 is sequentially connected and enclosed.
  • a medicine outlet 1009 is provided on the first arc-shaped portion 501121, and the medicine outlet 1009 connects the storage groove with the outside, and the medicine outlet 1009 is used to take out the medicine on the medicine delivery structure 200.
  • the inner wall of the annular plate 50112 is provided with at least one limiting groove extending along the first direction X, and the end of the limiting groove away from the bottom plate penetrates the annular plate 50112; the edge of the above-mentioned limiting component 40 is provided with at least one set of limiting blocks, The shape of the limit block is adapted to the limit slot, and each set of limit blocks is correspondingly inserted into the limit slot, so that the limit block and the limit slot cooperate to position the limit component.
  • a limit post is provided in the limit slot, and a card slot is also provided on the inner wall of the ring plate 50112. The limit post and the card slot are used to position and install the limit assembly 40 in the first direction X.
  • the aforementioned at least one limiting slot includes a first limiting slot 1001, a second limiting slot 1002, and a third limiting slot 1003.
  • the first limiting slot, the second limiting slot 1002, and the third limiting slot 1003 respectively extend from the annular plate 50112 in the first direction X.
  • the first limiting slot 1001 is provided at the junction of the first arc-shaped portion 501121 and the first flat portion 501123
  • the second limiting slot 1002 is provided at the junction of the first arc-shaped portion 501121 and the second flat portion 501124
  • the third The limiting slot 1003 is provided on the second arc-shaped portion 501122.
  • the first direction X is the direction in which the bottom plate 50111 faces the opening of the receiving slot.
  • the at least one limit post includes a first limit post 1004, a second limit post 1005, and a third limit post 1006.
  • the first limit post 1004 and the second limit post 1006 respectively extend from the bottom plate 50111 in the first direction X, and the extension heights of the first limit post 1004, the second limit post 1005 and the third limit post 1006 are the same.
  • the first limiting post 1004 is arranged in the first limiting slot 1001, the second limiting column 1005 is arranged in the second limiting slot 1002, and the third limiting column 1006 is arranged in the third limiting slot 1003.
  • the number of the third limiting posts 1006 is two, and the two third limiting posts 1006 are respectively disposed on both sides of the third limiting slot 1003.
  • the card slot includes a first card slot 1007 and a second card slot 1008.
  • the first card slot 1007 and the second card slot 1008 are respectively recessed from the inner wall of the ring plate 50112.
  • the first card slot 1007 and the second card slot 1008 are respectively provided on both sides of the first arc-shaped portion 501121, wherein the first card slot 1007 is provided on the side of the first arc-shaped portion 501121 facing the first flat plate portion 501123.
  • the two clamping slots 1008 are provided on the side of the first arc-shaped portion 501121 facing the second flat portion 501124.
  • Each first connecting member 10 or each second connecting member 20 is provided with two avoiding cuts, and the shape of the two avoiding cuts is U-shaped.
  • the two avoiding incisions are the first avoiding incision and the second avoiding incision.
  • the first avoiding incision and the second avoiding incision are arranged side by side along the first direction X.
  • the first avoiding incision and the second avoiding incision are used In avoidance limit component 40.
  • each first long bottom surface 101 away from the first short bottom surface 102 is provided with a first avoidance cut 1011 and a second avoidance cut 1012, the first avoidance cut 1011 and the second avoidance cut 1011
  • the avoidance cuts 1012 are distributed side by side along the first direction X.
  • the first relief cut 1011 is close to the end of the first long bottom surface 101 facing the bottom plate 50111
  • the second relief cut 1012 is close to the end of the first long bottom surface 101 facing the opening of the receiving slot.
  • a side of each second long bottom surface 201 away from the second short bottom surface 202 is provided with a first avoidance cut 2011 and a second avoidance cut 2012, the first avoidance cut 2011 and the second avoidance cut 2012 are along the first direction X Distributed side by side.
  • the first relief cut 2012 is close to the end of the second long bottom surface 201 facing the bottom plate 50111, and the second relief cut 2012 is close to the end of the second long bottom surface 201 facing the opening of the receiving slot.
  • the first avoidance cut 1011 of the first connector 10 and the first avoidance cut 2011 on the second connector 20 have the same shape; each of the first avoidance cuts (the first avoidance cut 1011 and the The first avoidance incision 2011) collectively surrounds an oval incision similar in shape to the drug delivery structure 200.
  • the second avoidance cut 1012 of the first connecting piece 10 and the second avoidance cut 2012 on the second connecting piece 20 have the same shape; each of the second avoidance cuts (the second avoidance cut 1012 and the second avoidance cut 2012 ) Are surrounded by an oval cut that surrounds the above-mentioned annular space.
  • the limiting component 40 includes a first limiting member 41 and a second limiting member 42.
  • the first limiting member 41 and the second limiting member 42 are respectively mounted on the inner wall of the annular plate 50112.
  • One end of the first limiting member 41 and one end of the second limiting member 42 are connected.
  • the first limiting member 41 and the second limiting member 42 form a non-closed C-shape, and the non-closed C-shape is similar to that of the ring plate 50112.
  • the shape of the inner wall is adapted, and the position of the non-closed annular opening corresponds to the position of the medicine outlet 1009.
  • the first limiting member 41 has a first head end 4101 and a first tail end 4102, the first head end 4101 is the first limiting member 41 toward the first arc portion 501121 At one end, the first tail end 4102 is an end of the first limiting member 41 facing away from the first arc-shaped portion 501121, and is located at the second arc-shaped portion 501122.
  • the second limiting member 42 is provided with a second head end 4201 and a second tail end 4202.
  • the second head end 4201 is the end of the second limiting member 42 facing the first arc portion 501121
  • the second tail end 4202 is the second One end of the limiting member 42 away from the first arc-shaped portion 501121 is located at the second arc-shaped portion 501122.
  • the first tail end 4102 is connected to the second tail end 4202, and there is a gap between the first head end 4101 and the second head end 4201, thereby forming the above-mentioned opening corresponding to the drug outlet 1009.
  • the first limiting member 41 includes a first bone location portion 410 and a first connection portion 412.
  • the number of the first bone location portion 410 is two, and the two first bone location portions 410 are connected to the first connection portion along the first direction X. Both ends of section 412.
  • the first bone position portion 410 and the first connecting portion 412 respectively extend in an arc shape from the first head end 4101 to the first tail end 4102.
  • One surface of the two first bone position portions 410 and the first connecting portion 412 respectively abuts against the first The arc-shaped portion 501121, the first flat plate portion 501123, and the second arc-shaped portion 501122.
  • the other surfaces of the two first bone position portions 410 respectively protrude relative to the first connecting portion 412, and one of the first bone position portions 410 is located in the first avoidance incision of the first connecting member 10 and the second connecting member 20, The other first bone portion 410 is located in the second avoidance incision of the first connector 10 and the second connector 20.
  • the second limiting member 42 includes a second bone location portion 420 and a second connecting portion 422, the number of the second bone location portion 420 is two, and the two second bone location portions 420 are connected to the second connection along the first direction X Both ends of section 422.
  • the second bone location portion 420 and the second connecting portion 422 respectively extend in an arc shape from the second head end 4201 to the second tail end 4202.
  • One surface of the two second bone location portions 420 and the second connecting portion 422 respectively abuts against the second The arc-shaped portion 121, the second flat plate portion 123 and the second arc-shaped portion 501122.
  • the other surfaces of the two second bone position portions 420 respectively protrude relative to the second connecting portion 422, and one of the second bone position portions 420 is located in the first avoidance incision of the first connecting member 10 and the second connecting member 20,
  • the other second bone portion 420 is located in the second avoidance incision of the first connector 10 and the second connector 20.
  • the first bone position portion 410 and the second bone position portion 420 are respectively inserted into the first avoidance incision and the second avoidance incision, which can reduce the difference between the first connecting member 10 and the second connecting member 20.
  • the volume of the accommodating space is convenient for storing small-volume medicines.
  • the number of the first bone position portion 410 and the second bone position portion 420 can be increased or decreased according to actual needs, for example, set to one, three, etc., respectively, as long as they can meet the requirements.
  • the demand is fine.
  • the protrusion height of the first bone position portion 410 relative to the first connecting portion 412 can be set according to actual needs
  • the protrusion height of the second bone position portion 420 relative to the second connecting portion 422 may be set according to actual requirements.
  • the lifting height can be set according to actual needs to meet the storage needs of different volumes of medicines.
  • a first limiting block 414 is provided at the first head end 4101 of the first limiting member 41, the number of the first limiting block 414 is two, and the two first limiting blocks 414 are respectively distributed along the first direction X On the two first bone positions 410.
  • the two first limiting blocks 414 are respectively provided on the side of the two first bone location portions 410 facing the inner wall of the annular plate 50112, and each first limiting block 414 faces away from the receiving groove from the corresponding first bone location portion 410 The direction is raised.
  • the two first limiting blocks 414 are respectively clamped in the first limiting slot 1001, wherein a first limiting block 414 facing the bottom plate 50111 abuts the first limiting post 1004.
  • the number of the first limit blocks 414 can be increased or decreased according to actual needs, for example, set to one, three, four, etc., and only the number of the first limit blocks 414 is required. At least one is sufficient, and at least one first limiting block 414 abuts the first limiting post 1004.
  • the second end 4201 of the second limiting member 42 is provided with a second limiting block 424, the number of the second limiting block 424 is two, and the two second limiting blocks 424 are respectively distributed along the first direction X On the two second bone positions 420.
  • Two second limiting blocks 424 are respectively provided on the side of the two second bone location portions 420 facing the inner wall of the annular plate 50112, and each second limiting block 424 faces away from the receiving slot from the corresponding second bone location portion 420 The direction is raised.
  • Two second limiting blocks 424 are respectively clamped in the second limiting slot 1002, wherein one second limiting block 424 facing the bottom plate 50111 abuts against the second limiting post 1204.
  • the second limit block 424 can be increased or decreased according to actual needs, for example, set to one, three, four, etc., and only the number of the second limit block 424 is at least Only one is sufficient, and at least one second limiting block 424 abuts against the second limiting post 1205.
  • the first end 4102 of the first limiting member 41 and the second end 4202 of the second limiting member 42 are fixedly connected.
  • two first splicing blocks 416 are provided at the first tail end 4102, and the two first splicing blocks 416 are respectively distributed on the two first bone locations 410 along the first direction X.
  • the two first splicing blocks 416 are respectively provided on the side of the two first bone location portions 410 facing the inner wall of the annular plate 50112, and each first splicing block 416 faces away from the corresponding first bone location portion 410 away from the receiving groove The direction is raised.
  • the two first splicing blocks 416 are respectively clamped in the third limiting slot 1003, and one of the first splicing blocks 416 facing the bottom plate 50111 abuts against the third limiting post 1006.
  • Two second splicing blocks 426 are provided at the second end 4202 of the third limiting post 1006, and the two second splicing blocks 426 are respectively distributed on the two second bone positions 420 along the first direction X.
  • Two second splicing blocks 426 are respectively provided on the side of the two second bone location portions 420 facing the inner wall of the annular plate 50112, and each second splicing block 426 faces a direction away from the receiving groove from the corresponding second bone location portion 420 Raised.
  • Two second splicing blocks 426 are respectively clamped in the third limiting slot 1003, wherein one second splicing block 426 facing the bottom plate 50111 abuts against the third limiting post 1006.
  • each first splicing block 416 and a corresponding second splicing block 426 can be spliced to form a third limiting block.
  • the shape of the third limiting block matches the shape of the third limiting slot 1003, and the third limiting block is clamped in the third limiting slot 1003.
  • the first splicing block 416 close to the bottom plate abuts against one of the third limiting posts 1006 in the third limiting groove 1003, and the second splicing block 426 close to the bottom plate abuts against the other third limit in the third limiting groove 1003.
  • Two connecting shafts 418 are also provided at the first tail end 4102, and the two connecting shafts 418 are respectively distributed on the two first bone positions 410 along the first direction X.
  • the two connecting shafts 418 are respectively disposed on a surface of the two first bone location portions 410 facing the inner wall of the annular plate 50112, and each connecting shaft 418 protrudes from a corresponding first bone location portion 410 in a direction away from the receiving groove.
  • Two connecting blocks 428 are also provided at the second tail end 4202, and the two connecting blocks 428 are respectively arranged on the side of the two second bone positions 420 facing the inner wall of the ring plate 50112.
  • the two connecting blocks 428 are respectively distributed on the two second bone positions 420 along the first direction X, and the position of each connecting block 428 corresponds to the position of a connecting shaft 418.
  • Each connecting block 428 is provided with a connecting through hole, and each connecting shaft 418 is inserted into a corresponding one of the connecting through holes, so that the first limiting member 41 and the second limiting member 42 are connected and fixed. It is understandable that, in some other embodiments, the number of connecting shafts 418 and connecting blocks 428 can be increased or decreased according to actual needs, for example, one or three can be set respectively, and only the first limiting member 41 and the first limiting member 41 and the The strength of the connection between the two limiting members 42 is sufficient.
  • connection structures may be provided between the first limiting member 41 and the second limiting member 42, such as screwing, clamping, riveting, bonding, etc., or,
  • the first limiting member 41 and the second limiting member 42 can also be integrally formed, which is not limited here.
  • a first locking block 419 is further provided at the first head end 4101 of the first limiting member 41, and the first locking block 419 is provided on the side of the first connecting portion 412 facing the inner wall of the ring plate 50112.
  • the first locking block 419 protrudes from the first connecting portion 412 in a direction away from the receiving slot, and the first locking block 419 is locked in the first slot 1007 so that the first limiting member 41 is fixed to the receiving slot 5011. That is, the first limiting block 414, the first limiting slot 1001, the first clamping block 419, the first clamping slot 1007, and the first limiting post 1004 cooperate to fix the first limiting member 41 in the housing ⁇ 5011.
  • the side of the first locking block 419 facing the bottom plate 50111 is set as a slope. When the first limiting member 41 is assembled with the receiving groove 5011, the slope can make the first locking block 419 better slide into the first locking slot.
  • a second locking block 429 is further provided at the second head end 4201 of the second limiting member 42, and the second locking block 429 is provided on the side of the second connecting portion 422 facing the inner wall of the ring plate 50112.
  • the second locking block 429 protrudes from the second connecting portion 422 toward the direction away from the receiving slot, and the second locking block 429 is locked in the second slot 1008 so that the second limiting member 42 is fixed to the receiving slot 5011. That is, the second limiting block 424, the second limiting slot 1002, the second clamping block 429, the second clamping slot 1008, and the second limiting post 1005 cooperate to fix the second limiting member 42 in the receiving ⁇ 5011.
  • the side of the second clamping block 429 facing the bottom plate 50111 is set as an inclined surface.
  • the inclined surface can enable the second clamping block 429 to slide into the second clamping groove better.
  • a medicine delivery mechanism 1000 which includes a base 1200, a connection assembly 1300, and the medicine delivery device 1100 in any of the above embodiments.
  • the base 1200 and the drug delivery device 1100 are detachably connected through the connection assembly 1300.
  • the receiving slot 5011 of the drug delivery device 1100 further includes a fixing plate 50113, and the fixing plate 50113 is disposed on the outer wall of the annular plate 50112.
  • the fixing plate 50113 has an L-shaped plate structure, an installation space is provided between the fixing plate 50113 and the annular plate 50112, and the connecting assembly 1300 is installed in the installation space.
  • the fixing plate 50113 includes a fixing portion 501131 and a bending portion 501132.
  • the fixing portion 501131 is connected to the bending portion 501132, and the fixing portion 501131 and the bending portion 501132 are arranged at a substantially right angle.
  • the fixing plate 50113 is located at an end of the annular plate 50112 away from the drug outlet 1009, the fixing portion 501131 is fixed to the first flat portion 501123 by fasteners, and the bending portion 501132 extends from the fixing portion 501131 to be connected to the second arc portion 501122.
  • the fixing plate 50113 is provided with two limiting through grooves 501133, and the two limiting through grooves 501133 respectively communicate the installation space with the outside.
  • Two limiting through-slots 501133 are respectively provided on the fixing portion 501131, and the two limiting through-slots 501133 are distributed side by side along the first direction X.
  • the ends of the two limiting through grooves 501133 facing away from each other are respectively provided with a first abutting wall
  • the ends of the two limiting through grooves 501133 facing each other are respectively provided with a second abutting wall.
  • the receiving slot 5011 further includes two extension plates 50114.
  • the two extension plates 50114 respectively extend outward from the receiving slot 5011 along two opposite surfaces in the first direction X to form an extension plate 50114.
  • the fixing plate 50113 is disposed between the two extension plates 50114, and two ends of the fixing plate 50113 are respectively connected to the two extension plates 50114.
  • Each extension plate 50114 is provided with an escape hole 501141, and two escape holes 501141 respectively communicate the installation space with the outside.
  • the receiving slot 5011 also includes two mounting blocks 501125, the mounting block 501125 is located in the mounting space, and the mounting block 501125 is fixed on the second arc-shaped portion 501122.
  • An installation groove is provided in the installation block 501125, and an opening is provided at one end of the installation groove away from the second arc-shaped portion 501122.
  • the two installation blocks 501125 are respectively provided with communicating grooves at their ends facing away from each other in the first direction X, and the communicating grooves communicate with the installation groove and the installation space.
  • the base 1200 is provided with a receiving groove with an open surface, and the shape of the receiving groove matches the shape of the drug delivery device 1100, and the drug delivery device 1100 is received in the receiving groove.
  • Two clamping grooves 1201 are respectively provided on the two side walls of the base 1200, and the clamping grooves 1201 communicate the receiving groove with the outside. When the drug delivery device 1100 is installed in the containing groove, each clamping groove 1201 is respectively connected with a corresponding escape hole 501141.
  • connection assembly 1300 includes two clamping members 1310 and two elastic members 1320.
  • the clamping member 1310 is installed on the side of the outer wall of the receiving groove 5011 facing the opening of the receiving groove, and is slidably fitted with the receiving groove 5011 along the first direction X, and the two clamping members 1310 are arranged opposite to each other along the first direction X.
  • the side of the clamping member 1310 facing away from the other clamping member 1310 is provided with a clamping portion 1312, and the inner wall of the base 1200 is provided with a clamping groove 1201 at the corresponding clamping portion 1312; the clamping member 1310 can be locked and unlocked Move between positions, where in the locked position, the clamping portion 1312 is inserted into the clamping slot 1201; in the unlocked position, the clamping portion 1312 exits the clamping slot 1201.
  • the elastic member 1320 corresponds to the clamping member 1310 one-to-one.
  • the two elastic members 1320 are disposed between the two clamping members 1310. One end of the elastic member 1320 abuts the clamping member 1310, and the other end abuts the receiving groove 5011.
  • the "sliding fit" mentioned in this application refers to two parts that are connected to each other in cooperation, and one part can slide in a specific direction relative to the other part.
  • the clamping member 1310 includes a base portion 1311, a clamping portion 1312, and a handle portion 1313, and the clamping portion 1312 and the handle portion 1313 are respectively connected to the base portion 1311.
  • the base 1311 is located between the two extension plates and includes a base plate 13111, a connecting plate 13112 and a contact plate 13113.
  • the base plate 13111 is adapted to the above-mentioned fixing plate 50113 and is in contact with the side of the fixing plate 50113 facing the accommodating space.
  • the base 1311 can move along the inner wall of the fixing plate 50113 along the first direction X; the connecting plate 13112 is provided on the base 1311 away from the other One side of the clamping member 1310 connects the two parts of the substrate 13111 that are bent with each other; one end of the abutment plate 13113 is fixed to the connecting plate 13112, and the other end extends in the first direction X toward the other clamping member 1310, which passes through The above-mentioned communicating groove.
  • the clamping portion 714 is provided on the side of the base portion 1311 away from the other clamping member 1310, and is specifically fixed to the connecting portion; the extension plate is provided with an escape hole for the clamping portion to pass through at the corresponding clamping portion.
  • the elastic member 1320 is received in the above-mentioned installation groove, and is in a compressed state. One end of the elastic member 1320 abuts against the inner wall surface of the installation groove away from the abutment plate 13113, and the other end abuts the abutment plate 13113.
  • the base 1311 When the clamping member 1310 is in the locking position, the base 1311 abuts against the elastic member 1320 and the extension plate respectively, and the clamping portion 1312 partially penetrates the escape hole, so that the clamping member 1310 can extend into the above-mentioned clamping groove, thereby
  • the drug delivery device 1100 is fixedly connected to the base 1200; when the clamping member 1310 is in the unlocked position, the clamping member 1310 further compresses the elastic member 1320, so that the clamping member 1310 can exit the above-mentioned clamping groove, so that the staff can The drug delivery device 1100 is taken out of the base 1200.
  • the handle portion 1313 extends from the base portion 1311 with a limiting through groove 501133, which is used for the staff to apply pressure to move the clip 1310 from the above-mentioned locked position to the unlocked position; of course, the handle portion 1313 is also convenient for the staff to hold and hold The drug delivery device.
  • the handle includes a first part and a second part. The first part is arranged in parallel with the opening cross-sectional profile of the above-mentioned receiving groove, the second part is arranged perpendicular to the first part, and both the first part and the second part are perpendicular to the above first direction X.
  • the first part is convenient for the staff to smoothly take out the drug delivery device 1100 from the containing groove when the drug delivery device 1100 is stored in the containing groove in a horizontal state.
  • the second part facilitates when the drug delivery device 1100 is stored in the containing groove in a vertical state, that is, the above-mentioned second arc-shaped part opens toward the containing groove, and the rest of the drug delivery device 1100 is wrapped by the wall of the containing groove, so that the staff can smoothly Take it out of the holding tank.
  • the medicine delivery mechanism in order to enable the medicine delivery structure 200 to travel orderly by an integer multiple of the set distance, so that the medicines in each storage space can move to the aforementioned medicine outlet in an orderly manner, the medicine delivery mechanism also It includes a photoelectric sensor and a controller; wherein, the above-mentioned set displacement is the distance between two adjacent accommodation spaces. Please refer to FIGS.
  • the drug delivery mechanism 1000 includes a drug delivery device 1100, a base 1200, a photoelectric sensor 1400, and a controller 1500.
  • the drug delivery structure 200 encloses an annular space 201
  • the side of the first connecting member 10 or the second connecting member 20 facing the annular space 201 is provided with a light-blocking sheet 204
  • a light-blocking sheet 204 corresponds to one of the above-mentioned Containment space 202.
  • the second connecting member 20 is provided with the above-mentioned light blocking sheet 204
  • the light blocking sheet 204 extends from the second short bottom surface 202 toward the annular space 201.
  • the light blocking sheet 204 is in the shape of a thin sheet.
  • the side of the second connecting member 20 facing the annular space 201 is further provided with a light blocking sheet 2041 connected to the light blocking sheet 204.
  • the photoelectric sensor 1400 is housed in the aforementioned annular space 201, and includes a transmitter 1410 and a receiver 1420, and the transmitter 1410 and the receiver 1420 are spaced apart along the first direction X.
  • the position of the light blocking sheet 204 is located between the transmitter 1410 and the receiver 1420.
  • the light blocking sheet 204 is used to extend between the transmitter 1410 and the receiver 1420 during the movement of the drug delivery structure 200 to shield the transmitter 1410, that is, to prevent the receiver 1420 from receiving the light signal emitted by the transmitter 1410; photoelectric sensor 1400 is used to measure the number of times the emitter 1410 is blocked by the light blocking sheet 204 during the unidirectional movement of the drug delivery structure 200.
  • each second connecting member 20 has a light-blocking sheet 204
  • the light-blocking sheet 204 corresponds to the containing space 202 in a one-to-one manner, the set displacement per unit of travel of the drug delivery structure 200 (the distance between two adjacent containing spaces) ), a light blocking sheet 204 blocks the emitter of the photoelectric sensor 1400 once, and the photoelectric sensor 1400 counts once.
  • controller 1500 is installed on the base 1200 and connected to the source drive module 502 and the photoelectric sensor 1400 respectively, so that the source drive module 502 can be controlled to run in an orderly manner, so that the drug delivery structure is 200 integer Times the set displacement.
  • the drug delivery mechanism 1000 can monitor whether the drug delivery structure 200 has traveled an integer multiple of the set displacement through the photoelectric sensor 1400; the controller accurately controls the source driving module 502 to run in time according to the number of times the photoelectric sensor 1400 times to block.
  • the medicines in each storage space 202 can be moved to the medicine outlet 1009 in an orderly manner to realize material dropping.
  • the medicine cabinet system needs to check whether there are medicines in each storage space 202 of the medicine transmission device.
  • the inventory process is to drive the drug delivery mechanism 1000 to run a full circle through the aforementioned source driving module 502, and the corresponding sensors detect whether there are drugs in each storage space 202.
  • the drug delivery structure 200 needs to be driven to a specific preset position, so that the benchmark for each inventory can be set to be uniform, but the current structure of the drug delivery mechanism 1000 cannot detect whether the drug delivery structure 200 moves to The above-mentioned preset position cannot be stably carried out in the inventory process.
  • the medicine delivery mechanism provided in the embodiment of the present application further includes a magnet 1600 and a Hall element 1610.
  • the magnet 1600 is mounted on the drug delivery structure 200. In this embodiment, it is specifically accommodated in a accommodating space 202 and arranged close to the bottom plate of the accommodating slot 5011.
  • Hall element 1610 For the aforementioned Hall element 1610, please continue to refer to FIG. 26 and FIG. 27, where the base 1200 is installed and is arranged close to the drug delivery structure 200.
  • the Hall element 1610 is disposed close to the bottom plate of the receiving slot 5011, and is disposed on both sides of the bottom plate with the magnet 1600.
  • the Hall element 1610 is used to cooperate with the magnet 1600 to detect whether the drug delivery structure 200 moves to a preset position.
  • the device 1500 controls the source driving module 502 to stop running, so that the medicine delivery structure 200 is maintained at the preset position.
  • the controller 1500 can obtain the position of the medicine delivery structure 200 at this time, and set it as the "zero position" as a reference in the process of inventorying medicines, and control the movement of the medicines in each storage space 202 to the above-mentioned medicine outlet 1009 Benchmark. It is worth mentioning that when the medicine delivery structure 200 is located at the aforementioned preset position, a receiving space 202 is exactly aligned with the aforementioned medicine outlet 1009.
  • the medicine delivery mechanism 1000 further includes a photoelectric switch 1620 connected to the controller 1500.
  • the photoelectric switch 1620 has substantially the same structure as the aforementioned photoelectric sensor 1400. It is housed in the aforementioned annular space 201 and specifically includes a light emitter 1621 and a light receiver 1622. Along the above-mentioned first direction X, the light emitter 1621 and the light receiver 1622 are spaced apart; one of the light barriers 204 is used to extend into the light emitter 1621 and the light receiver 1621 when the magnet 1600 approaches the Hall element 1610.
  • the light and light emitters 1621 are shielded, so that the magnet 1600, the Hall element 1610, a light blocking sheet 204, and the photoelectric switch 1620 cooperate to detect whether the drug delivery structure 200 moves to the aforementioned preset position. Specifically, after the Hall element 1610 senses the magnet 1600, when the light emitter 1621 of the photoelectric switch 1620 is blocked for the first time, that is, the medicine delivery structure 200 travels to a preset position.
  • the solution of simultaneously determining the preset position by combining the Hall element 1610 and the photoelectric switch 1620 is accurate and reliable.
  • the medicine delivery mechanism 1000 further includes a laser 1700 connected to the above-mentioned controller 1500.
  • the laser 1700 includes a transmitting end 1710 and a receiving end 1720.
  • the transmitting end 1710 and the receiving end 1720 are respectively arranged on both sides of the drug delivery structure 200, and are respectively installed on the base 1200; the laser light emitted by the transmitting end 1710 can pass through the receiving space 202 and be transmitted by the receiving end 1720 receive.
  • the containing space containing the magnet 1600 corresponds to the optical path of the laser 1700, that is, the laser light emitted by the emitting end 1710 passes through the containing space 202 containing the magnet 1600.
  • the storage space 202 containing the magnet 1600 is not used to contain medicines.
  • the intensity of the laser light received by the receiving end 1720 is the same or substantially the same; when the receiving end 1720 receives
  • the controller can prompt the staff to correct the intensity of the laser output from the laser 1700 through an output module (such as a display, a speaker, etc.) not shown.
  • the drug delivery mechanism further includes a reflector 1730, which is mounted on the base 1200 and used to reflect the laser light emitted by the transmitting end 1710, so that the transmitting end 1710 can be installed in parallel on the base 1200 facing the top cover 5012.
  • the wall surface thereby reducing the overall volume occupied by the drug delivery mechanism 1000; at the same time, it is also convenient to adjust the laser emitted by the transmitting end 1710 to fall on the receiving end 1720, so as to avoid the installation error of the transmitting end 1710 and the receiving end 1720 causing the receiving end 1720 to fail.
  • the reflecting mirror 1730 includes a mirror body 1731 and a mirror handle 1732.
  • the mirror body 1731 is used to reflect the laser light emitted by the emitting end 1710.
  • One end of the mirror handle 1732 is fixed to the mirror body 1731, and the other end extends away from the mirror body 1731;
  • the base 1200 is provided with a mounting hole matching the shape of the mirror handle 1732, and the mirror handle 1732 is installed in the mounting hole of the base 1200 with interference.
  • the angle of the reflector 1730 can be easily adjusted, so as to accurately reflect the laser light emitted by the transmitting end 1710 to the receiving end 1720, the mirror handle 1732 There is also a jack.
  • the insertion hole is provided at an end of the mirror handle 1732 away from the mirror body 1731, and its axis is perpendicular to the extending direction of the mirror handle 1732. It is understandable that, in other embodiments of the present application, the insertion hole may also start from the end of the lens handle 1732 away from the lens body 1731 and extend parallel to the lens handle 1732; in this case, an L-shaped rod is used. The purpose of rotating the mirror handle 1732 can be achieved.
  • the base 1200 is provided with a medicine passage 1202 at a position corresponding to the above-mentioned medicine outlet 1009, and medicines can be dropped to the outside of the medicine delivery mechanism 1000 through the medicine outlet 1009 and the medicine passage 1202 in sequence. If the medicine channel 1202 is always in communication with the outside of the medicine delivery mechanism 1000, the medical staff can only take out medicines sequentially from the storage space 202 closest to the medicine outlet 1009 to the storage space 202 far from the medicine outlet 1009, instead of directly. The medicine at the desired position is taken out, while the medicine between the medicine outlet 1009 and the desired position is not taken out.
  • the medication delivery mechanism 1000 provided in the embodiment of the present application further includes a gate 1800 and a driving assembly 1900.
  • the driving assembly 1900 is respectively connected with the gate 1800 and the aforementioned controller 1500, and is used to drive the gate 1800 to move in the open position and the closed position.
  • the gate 1800 opens the drug passage 1202, and the drug passage 1202 connects the drug outlet 1009 with the external environment of the drug delivery mechanism 1000; in the closed position, the gate 1800 blocks the drug passage 1202.
  • the base 1200 includes a bottom plate 1210, a first side plate 1220, a second side plate 1230, a front end plate 1240, and a rear end plate 1250.
  • the bottom plate 1210, The first side plate 1220, the second side plate 1230, the front end plate 1240, and the rear end plate 1250 can be detachably connected to form a containing groove, and the front end plate 1240 is provided with a medicine through groove 1202.
  • the front end plate 1240 faces the above-mentioned medicine outlet 1009, and is provided with the above-mentioned medicine through groove.
  • the gate 1800 is slidably installed on the front end plate 1240, and the gate 1800 is slidable between an open position and a closed position.
  • FIGS. 32 to 34 respectively show the connection schematic diagram of the front end plate 1240, the gate 1800 and the drive assembly 1900, the exploded schematic diagram of the gate 1800 and the drive assembly 1900, and the three-dimensional schematic view of the gate 1800, combined with other drawings.
  • the side of the front end plate 1240 facing the drug delivery device 1100 is provided with a protruding strip 1241 extending in a predetermined direction.
  • the side of the gate 1800 facing the protruding strip 1241 is provided with a sliding groove 1810 adapted to the protruding strip 1241.
  • the above-mentioned protruding bar 1241 is inserted into the sliding groove 1810, so that the gate 1800 and the base 1200 are slidably fitted in the above-mentioned predetermined direction.
  • the convex strip 1241 extends in a direction perpendicular to the bottom plate 1210.
  • the number of the protruding strips 1241 is two, and the two protruding strips 1241 are respectively provided with two sides of the drug passage; correspondingly, the number of the sliding grooves 1810 is also two, and one sliding groove corresponds to one protruding strip 1241 .
  • the driving assembly 1900 includes a driving motor 1910, a gear 1920, and a rack 1930.
  • the driving motor 1910 is installed on the base 1200 and connected to the above-mentioned controller 1500.
  • the gear 1920 is fixed to the output shaft of the drive motor 1910.
  • the rack 1930 is fixed to the gate 1800 and extends in a direction parallel to the above-mentioned convex bar 1241.
  • the rack 1930 meshes with the gear 1920.
  • the medicine delivery mechanism 1000 can drive the gear 1920 to revolve through the driving motor 1910, thereby driving the rack 1930 and the gate 1800 to slide between the open position and the closed position.
  • the gate 1800 is in the closed position; when the medicine desired to be taken out moves to the medicine passage 1202 under the drive of the medicine delivery structure 200, the controller 1500 controls the driving motor 1910 to operate to move the gate 1800 to the open position. After the medicine is taken out, the controller 1500 controls the driving motor 1910 to run in the reverse direction to move the gate 1800 to the closed position.
  • the rack 1930 and the gate 1800 are integrally formed; more preferably, the rack 1930 and the gate 1800 are integrally formed by injection molding. It can be understood that, in other embodiments of the present application, the rack 1930 and the gate 1800 may also be arranged separately, and then fixed by screwing, clamping, welding or other processes.
  • the medicine delivery mechanism 1000 further includes a first sensor 1940 and a second sensor 1950.
  • the first sensing element 1940 and the second sensing element 1950 are both connected to the controller 1500.
  • the first sensing element 1940 is used to detect whether the gate 1800 moves to the open position
  • the second sensing element 1950 is used to detect Whether the gate 1800 moves to the closed position.
  • the gate 1800 has a shielding strip 1820.
  • the gate 1800 When the shielding strip 1820 moves to the first sensing element 1940, the gate 1800 is in the open position; the first sensing element 1940 detects that the gate 1800 reaches the open position, and the controller controls the driving motor 1910 to stop running to make The medicine can be dropped out of the medicine delivery mechanism 1000 smoothly.
  • the gate 1800 When the shielding strip 1820 moves to the second sensing element 1950, the gate 1800 is in the closed position to prevent the medicine from falling out of the medicine delivery mechanism 1000.
  • the first sensing element 1940 and the second sensing element 1950 are both photoelectric sensors; when the shielding bar 1820 moves to the first sensing element 1940, it extends between the transmitter and the receiver of the first sensing element 1940 ; When the shielding bar moves to the second sensing element 1950, it extends between the transmitter and the receiver of the second sensing element 1950.
  • FIG. 35 shows a medicine cabinet 9000 provided by one embodiment of the present application.
  • the medicine cabinet 9000 has a drawer-like structure and includes a cabinet frame 5000 and a plurality of drawer units 4000.
  • the cabinet frame 5000 is provided with storage space; the drawer unit 4000 is slidably installed on the cabinet frame 5000 and can be extended or retracted into the storage space; each drawer unit 4000 is arranged in sequence from top to bottom as shown in the figure to form a multi-layer drawer
  • the medicine cabinet 9000 of the unit 4000 It is worth mentioning that "multiple" in this application means more than two. Of course, in other embodiments of the present application, the number of the drawer unit 4000 may also be only one.
  • the drawer unit 4000 includes a drawer frame 4100, a delivery mechanism 4200, and at least one medicine delivery mechanism group 4300.
  • the drawer rack 4100 is slidably installed on the cabinet rack 5000 and can move between the extended position and the retracted position. It is provided with a containing cavity for accommodating the delivery mechanism 4200 and the drug delivery mechanism group 4300. .
  • the drawer rack 4100 includes a drawer bottom, a first drawer side panel, a second drawer side panel, a drawer front panel (not shown) facing the external environment of the medicine cabinet 9000, and a drawer front panel (not shown) accommodated in the above-mentioned storage space and opposite to the drawer front panel
  • the drawer rear panel (not marked), the first drawer side panel, the second drawer side panel, the drawer front panel, and the drawer rear panel are all connected to the drawer bottom panel to enclose a receiving cavity 4110.
  • FIGS. 37 and 38 respectively show a perspective view of the drawer unit 4000 with the drawer frame 4100 and the drug delivery mechanism group 4300 hidden, and a perspective view of the delivery mechanism 4200.
  • the delivery mechanism 4200 is used for Receive the medicine delivered by the above-mentioned medicine delivery mechanism group 4300.
  • the conveying mechanism 4200 includes a driving wheel 4210, a driven wheel 4220, a conveying belt 4230, and a power assembly 4240.
  • the driving wheel 4210 and the driven wheel 4220 can be rotatably installed on the drawer frame 4100, and they are arranged at intervals along the second horizontal direction Y as shown in the figure; the conveyor belt 4230 is in a separate ring shape, which is spared on the driving wheel 4210 With the driven wheel 4220.
  • the power assembly 4240 is located close to the rear end plate of the drawer. It is connected with the driving wheel 4210. It is used to drive the driving wheel 4210 to rotate so that the conveyor belt 4230 rotates around the driving wheel driven wheel 4220, so that the horizontal area on the top of the conveyor belt 4230 can be The medicine is transported, and the medicine is driven to the end of the conveyor belt 4230 near the front plate of the drawer.
  • the power assembly 4240 is disposed near the rear end plate of the drawer, and includes a power motor 4241, a first gear 4242 and a second gear 4243.
  • the power motor 4241 is fixedly installed on the drawer frame 4100, and the output shaft of the power motor 4241 is connected with the first gear 4242; the second gear 4243 is coaxially fixed with the driving wheel 4210 and meshes with the first gear 4242.
  • the driving wheel is arranged close to the drawer rear panel
  • the driven wheel is arranged close to the drawer front panel, that is, the second direction Y in this embodiment is the direction of the drawer rear panel pointing to the drawer front panel.
  • the medication delivery mechanism group 4300 includes two above-mentioned medication delivery mechanisms 1000 arranged oppositely, and the two medication delivery mechanisms 100 are along a direction perpendicular to the second direction Y They are separately arranged on both sides of the conveyor belt 4230, and the medicine outlets 1009 of the two medicine delivery mechanisms 1000 are arranged facing each other. In this way, all the medicines sent from the medicine delivery mechanism 1000 will fall on the conveyor belt 4230, so that the conveyor belt 4230 will travel down to the end of the conveyor belt 4230 away from the power assembly 4400 for the user to take.
  • the drawer unit 4000 includes multiple sets of medicine delivery mechanism groups 4300, and the multiple sets of medicine delivery mechanism groups 4300 are arranged at intervals along the second direction Y described above.
  • the conveying mechanism 4200 further includes a partition 4250 fixedly connected to the drawer frame 4100.
  • the partition 4250 is arranged above the conveyor belt 4230 and extends in a direction parallel to the conveyor belt. It divides the conveyor belt into two conveying channels, and each conveying channel is used to transport the drop of a line of drug delivery mechanisms adjacent to it. drug.
  • the partition 4250 By arranging the partition 4250, the medicine delivered by each row of the drug delivery mechanism 1000 can be transported along a conveying channel alone on the side of the conveyor belt 4230 close to the drawer front plate, which can ensure that the medicines of the two rows of drug delivery mechanisms 1000 are delivered independently and avoid mixing.
  • the drawer unit 4000 further includes a receiving table 4400 close to the driven wheel 4220 and used for receiving the medicine delivered by the conveying mechanism 4200, so as to facilitate the user to take the medicine from the receiving table 4400.
  • the receiving platform 4400 is a box-shaped structure, which is accommodated in the above-mentioned accommodating cavity, and is arranged at the end of the conveyor belt near the front end plate of the drawer; the receiving platform 4400 is used to receive the conveyor belt Drugs delivered to the above-mentioned preset location.
  • the number of the receiving stations 4400 is two, and the two receiving stations 4400 are arranged side by side, and correspond to the above-mentioned conveying channels one-to-one.
  • the receiving platform 4400 is provided with an inclined surface at one end close to the conveyor belt so that the medicines slide to the bottom of the receiving platform through the inclined surface.
  • the drawer unit 4000 further includes a sensor 4500 connected to the controller 1500.
  • the sensor 4500 is installed on the drawer frame 4100 and connected to the receiving table 4400, and is used to sense whether the receiving table 4400 has medicines.
  • the sensor 4500 is a weight sensor; when the medicine transported by the conveyor belt 4230 falls to the receiving table 4400, the weight of the receiving table 4400 will change, so it can be judged according to the gravity change of the receiving table 4400. Medicine dropped.
  • the medicine cabinet 9000 provided in the embodiment of the present application includes a cabinet rack 5000 and a drawer unit 4000.
  • the drawer unit 4000 includes the above-mentioned medicine delivery mechanism 1000, so the medicine cabinet 9000 can also realize the function of a single medicine withdrawal.
  • the drawer unit 4000 includes a drawer rack 4100, a delivery mechanism 4200, and a number of drug delivery mechanisms 1000; the number of drug delivery mechanisms 1000 are planned and displayed in the drawer rack 4100, and the delivery mechanism 4200 uniformly transports the drugs delivered by the drug delivery mechanisms 1000. Therefore, it is possible to avoid the disadvantage that a separate delivery mechanism 4200 is provided for each drug delivery mechanism 1000, which causes a large space.

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

一种药物传送结构、药物传送装置及药柜。药物传送结构（200）通过第一连接件（10）和第二连接件（20）两两扣合后，再由固定柱固定。因此，第一连接件（10）和第二连接件（20）的两短底面（102、202）连接后与其两长底面（101、201）形成收容空间，用于收容药物。在药物传送结构转动的过程中，能够带动收容空间内的药物运动，进而实现药物传送。

Description

药物传送结构、药物传送装置及药柜
本申请要求享有于2019年12月24日向中国国家知识产权局提交的名称为“药物传送结构及其装置”的中国专利申请201911347343.4的优先权，该申请的全部内容通过引用并入本申请中。
技术领域
本申请涉及药物传送技术领域，尤其涉及一种药物传送结构、药物传送装置及药柜。
背景技术
随着现代化的发展，医疗电子设备越来越普及，智慧医院对药品管控的精细化程度越来越高。传统的药品管理是由药品管理员或医护人员手工登记，以尽量保证这类药品按照规定进行管理和存储，但是手工登记难免会出现漏记、错记或者药品丢失等情况，难以保证药品的安全，而且药品管理效率低下。
新申请内容
基于此，有必要提供一种能够单支管理的药物传送结构。
本申请实施例解决其技术问题采用以下技术方案：
一种药物传送结构，包括固定柱、若干个第一连接件和若干个第二连接件；
所述第一连接件大体呈L型，所述第一连接件的短底面的两长侧边分别设有第一连接柱；
所述第二连接件大体呈L型，所述第二连接件的短底面的两长侧边分别设有与该第一连接柱对应的第二连接柱；
若干个所述第一连接柱与若干个所述第二连接柱两两扣合后，再通过所述固定柱固定连接形成所述药物传送结构。
本申请实施例解决其技术问题还采用以下技术方案：
一种药物传送装置，包括上述药物传送结构、用于提供驱动力的源驱动模块、主驱动模块及外壳；
所述源驱动模块的驱动力传导给所述主驱动模块；所述主驱动模块用于驱动所述药物传送结构绕所述主驱动模块转动；所述药物传送结构转动的时候，带动置于所述药物传送结构中的药物运动；所述外壳用于收容所述源驱动模块、所述主驱动模块及所述药物传送结构；所述外壳还设有药物出口。
本申请实施例解决其技术问题还采用以下技术方案：
一种药柜，包括上述的药物传送机构。
上述药物传送结构通过第一连接件和第二连接件两两扣合后，再由固定柱固定，因此，第一连接件和第二连接件的两短底面连接后与其两长底面形成收容空间，用于收容药物。在药物传送结构转动的过程中，能够带动收容空间内的药物运动，进而实现药物传送。每一相对设置的第一连接件与第二连接件之间形成收容药品的收容空间，该收容空间便于储存单支药品，从而实现单支药品的管理。
上述药物传送装置通过源驱动模块提供驱动力，使主驱动模块转动，进而主驱动模块带动药物传送结构运动，置于药物传送结构中的药物则能跟随药物传送结构运动，使用外壳收容源驱动模块、主驱动模块及药物传送结构，能够避免药物在传送过程中散落，进而实现药物传送。相比传统的药物传送装置来说，减少了元器件，进而降低产品成本。
附图说明
为了更清楚地说明本申请实施例中的技术方案，下面将对实施例描述中所需要使用的附图作简单地介绍，显而易见地，下面描述中的附图仅仅是本申请的一些实施例，对于本领域普通技术人员来讲，在不付出创造性劳动的前提下，还可以根据这些附图示出的结构获得其他的附图。
图1为本申请其中一实施例提供的药物传送结构示意图；
图2为第一连接件的结构示意图；
图3为第二连接件的结构示意图；
图4为第三连接件的结构示意图；
图5为药物传送装置的模块图；
图6为主驱动模块、传动模块、源驱动模块的结构示意图；
图7为从驱动模块的结构示意图；
图8为药物传送装置的结构示意图之一；
图9为药物传送装置的结构示意图之二；
图10为本申请其中一实施例提供的药物传送装置隐藏顶盖后的立体示意图；
图11为图10中药物传送装置隐藏顶盖后的分解示意图；
图12为图10中收容槽的一个方向的立体示意图；
图13为图10中收容槽的另一个方向的立体示意图；
图14为图10中收容槽的又一个方向的立体示意图
图15为图10中第一连接件的一个方向的立体示意图；
图16为图10中第二连接件的一个方向的立体示意图；
图17为图10中限位组件的一个方向的立体示意图；
图18为图10中限位组件的另一个方向的立体示意图；
图19为图10中限位组件的又一个方向的立体示意图；
图20为本申请其中一实施例提供的药物传送机构的立体示意图；
图21为图20中底座的局部分解示意图；
图22为图20中底座的立体示意图；
图23为图20中卡接件的立体示意图；
图24为图20中药物传送机构的沿A-A线的剖切示意图；
图25为本申请其中一实施例提供的药物传送机构的立体示意图；
图26为图25中药物传送结构的一个方向的剖切示意图；
图27为图25中药物传送结构的分解示意图；
图28为图25中药物传送装置的分解示意图；
图29为图25中药物传送装置隐藏外壳后的一个方向的立体示意图；
图30为图25中药物传送装置隐藏外壳后的另一个方向的立体示意图；
图31为本申请其中一实施例的药物传送机构的分解示意图；
图32为图31中前端板、闸门与驱动组件的连接示意图；
图33为图31中闸门与驱动组件的分解示意图；
图34为图31中闸门的立体示意图；
图35为本申请其中一实施例提供的药柜的立体示意图；
图36为图35中抽屉单元的立体示意图；
图37为图36抽屉单元隐藏抽屉架及药物传送机构组后的立体示意图；
图38为图36中输送机构的立体示意图。
具体实施方式
为使本申请的上述目的、特征和优点能够更加明显易懂，下面结合附图对本申请的具体实施方式做详 细的说明。在下面的描述中阐述了很多具体细节以便于充分理解本申请。但是本申请能够以很多不同于在此描述的其它方式来实施，本领域技术人员可以在不违背本申请内涵的情况下做类似改进，因此本申请不受下面公开的具体实施的限制。
需要说明的是，当元件被称为“固定于”另一个元件，它可以直接在另一个元件上或者也可以存在居中的元件。当一个元件被认为是“连接”另一个元件，它可以是直接连接到另一个元件或者可能同时存在居中元件。本文所使用的术语“垂直的”、“水平的”、“左”、“右”以及类似的表述只是为了说明的目的，并不表示是唯一的实施方式。
除非另有定义，本文所使用的所有的技术和科学术语与属于本申请的技术领域的技术人员通常理解的含义相同。本文中在本申请的说明书中所使用的术语只是为了描述具体的实施例的目的，不是旨在于限制本申请。以上所述实施例的各技术特征可以进行任意的组合，为使描述简洁，未对上述实施例中的各个技术特征所有可能的组合都进行描述，然而，只要这些技术特征的组合不存在矛盾，都应当认为是本说明书记载的范围。
如图1所示，药物传送结构示意图。
一种药物传送结构200，包括固定柱(未标示)、若干个第一连接件10和若干个第二连接件20；
所述第一连接件10大体呈L型，所述第一连接件10的短底面的两长侧边分别设有第一连接柱103；
所述第二连接件20大体呈L型，所述第二连接件20的短底面的两长侧边分别设有与该第一连接柱103对应的第二连接柱；
若干个所述第一连接柱103与若干个所述第二连接柱两两扣合后，再通过所述固定柱(未标示)固定连接形成所述药物传送结构200。
请结合图2。第一连接件10包括第一长底面101、第一短底面102及第一连接柱103。其中，第一长底面101与第一短底面102大体呈垂直设置，第一长底面101与第一短底面102相交形成的边上设置第一连接柱103，第一短底面102另一条边上平行设置第一连接柱103。即第一短底面102的两相对长侧边上设置两平行的第一连接柱103。
请结合图3。第二连接件20包括第二长底面201、第二短底面202及第二连接柱203。其中，第二长底面201与第二短底面202大体呈垂直设置，第二长底面201与第二短底面202相交形成的边上设置第二连接柱203，第二短底面202另一条边上平行设置第二连接柱203。即第二短底面202的两相对长侧边上设置两平行的第二连接柱203。
第一连接件10的第一长底面101与第二连接件20的第二长底面201贴合连接，第一连接件10的第一短底面102与第二连接件20的第二短底面202抵接。因此第一长底面101边缘的第一连接柱103能够与第二长底面201边缘的第二连接柱扣合，第一短底面102边缘的第一连接柱103能够与第二短底面202边缘的第二连接柱扣合。第一连接柱103与第二连接柱之间再通过固定柱(未标示)进行固定，进而实现第一连接件10与第二连接件20的固定连接。若干个第一连接件10与第二连接件20扣合后，可形成药物传送结构200。
更具体地，第一连接件10与第二连接件20交替设置，相邻的第一连接件10及第二连接件20通过上述第一连接柱103与第二连接柱223扣合后，再通过固定柱固定连接，以形成上述环形的药物传送结构200，并围成一环形空间(图1所示的腰形空间)。值得注意的是，在相邻的两第一连接件10与位于该两第一连接件10间的第二连接件20之间，第二连接件20的第二短底面202与一第一连接件10的第一短底面102相向设置，则该相向设置的第一连接件10与第二连接件20共同围合成用于收纳药品的收容空间；同时，该第二连接件20的第二短底面202与另一第一连接件10的第一短底面102背向设置，第一长底面101及第二长底面201背离环形空间设置，依此规律连接成上述药物传送结构200。
第一连接柱103包括第一圆形连接柱1031和第一半圆形连接柱1032。其中，第一圆形连接柱1031设置于第一短底面102的两长侧边的边缘，第一半圆形连接柱1032设于第一短底面102的两长侧边的中间位置。
第二连接柱包括第二圆形连接柱2031和第二半圆形连接柱2032，第二圆形连接柱2031和第二半圆形连接柱2032设置位置与第一圆形连接柱1031和第一半圆形连接柱1032的位置互补对应，即第一连接柱103能够与第二连接柱刚好扣合。
第一圆形连接柱1031、第一半圆形连接柱1032、第二圆形连接柱2031、第二半圆形连接柱2032均为中空的，能够使得固定柱(未标示)穿设于第一圆形连接柱1031、第一半圆形连接柱1032、第二圆形连接柱2031、第二半圆形连接柱2032，进而实现第一连接件10与第二连接件20的固定。
药物传送结构200的长度可根据用户实际需求设置，因此，第一连接件10和第二连接件20的数量可根据用户实际需求自由设置。
在本实施例中，药物传送结构200径向截面大体为椭圆形，因此，在椭圆的两顶端位置，第一连接件10及第二连接件20会因受到拉力出现张开。值得一提的是，在其他一些实施例中，第一连接件与第二连接件为一体式结构，收容空间的两侧仅分别具有一隔板，则药物传送结构端部区域相邻的两隔板均会向外张开，致使收容空间整体变大，导致药品自由活动的空间因此增大；同时药物传送结构面向环形空间的部分会因此大幅度弯曲变形。而本实施例中，收容空间由相向设置的第一连接件10与第二连接件20围成，每一收容空间的两侧分别具有两隔板(即上述第一长底面和第二长底面)，相邻的两收容空间之间形成一扇形空间，该扇形空间能够占用一部分空间，进而可减小收容空间整体张开的角度，即是药品的自由活动的空间也较小。同时，相向设置的第一连接件10与第二连接件20在张开后相互倾斜呈一夹角，故每一连接件变形的幅度均较小，该药物传送结构200的整体工作寿命更长。可以理解的是，在本申请的其他实施例中，药物传送结构200的形状亦可以是圆形、圆角矩形等，在此不一一限定。
第一长底面101远离第一短底面102的一边缘设置有U型切口。第二长底面201远离第二短底面202的一边缘设置有与第一长底面101U型切口完全一致的U型切口。
在药物传送结构200需要传送较小体积药品(如安瓿瓶)时，可以沿所有U型切口设置垫圈，能够缩小第一连接件10与第二连接件20形成的收容空间。在传送较大体积药品(如西林瓶)时，就取消垫圈。采用这种设置能够使药物传送结构200适用多种体积的药品，且在传送较小体积药品时，避免收容空间过大而误放多支药品。
请结合图4。在本实施例中，药物传送结构200还包括第三连接件30，所述第三连接件30的两长侧边分别设置有所述第一连接柱103和所述第二连接柱203，所述第三连接件30的第一连接柱103与所述第二连接件20的第二连接柱203扣合再通过所述固定柱(未标示)固定连接，所述第三连接件30的第二连接柱与所述第一连接件10的第一连接柱103扣合再通过所述固定柱(未标示)固定连接。第三连接件30用于连接相对设置的第一连接件10与第二连接件20；即是，第一连接件10、第三连接件30与第二连接件20依次交替设置，以扩展收容空间的整体体积，便于管理更大体积的药品。第三连接件30的设置，便于厂商在不必改变第一连接件10与第二连接件20的尺寸规格的情况下，即可通过选择性地使用或不使用第三连接件30，实现两种规格上述药物传送结构及相关装置的生产。
第三连接件30为片状，第三连接件30包括第三长底面301和设置于第三长底面301相对两长侧边上的第一连接柱103和第二连接柱203。设置第三连接件30是为了加宽第一连接件10与第二连接件20形成的收容空间，便于管控更大体积的药品。
在本实施例中，所述第一连接柱103包括间断设置的第一圆形连接柱1031和第一半圆形连接柱1032，所述第一圆形连接柱1031和所述第一半圆形连接柱1032在一条轴线上；所述第二连接柱包括间断设置的 第二圆形连接柱2031和第二半圆形连接柱2032，所述第二圆形连接柱2031和所述第二半圆形连接柱2032在一条轴线上。
在其他实施例中，第一连接柱103可以只包括一个第一圆形连接柱1031，第二连接柱也可以只包括一个第二圆形连接柱2031。即第一连接柱103和第二连接柱能够通过固定柱(未标示)固定即可。
基于上述所有实施例，第一圆形连接柱1031、第一半圆形连接柱1032、第二圆形连接柱2031、第二半圆形连接柱2032的径向直径相等。第一短底面102、第二短底面202、第三长底面301的宽度相等。
请结合图1。在本实施例中，药物传送结构200还包括挡光片204，所述挡光片204垂直设置于所述第一连接件10的短底面或所述第二连接件20的短底面上。
请结合图3。在本实施例中，挡光片204设置于第二连接件20的第二短底面202上，且与第二连接件20的第二短底面202垂直。挡光片204用于遮挡激光计数器发送的光，每遮挡一次则计数一次。
上述药物传送结构200通过第一连接件10和第二连接件20两两扣合后，再由固定柱(未标示)固定，因此，第一连接件10和第二连接件20的两短底面连接后与其两长底面形成收容空间，用于收容药物，相邻两个第一连接件10和第二连接件20形成的收容中，只能放置一支药品。在药物传送结构200转动的过程中，能够带动收容空间内的药物运动，进而实现药物传送。
若药品体积较大时，则增加第三连接件30，对收容空间进行扩展，即第一连接件10、第二连接件20、第三连接件30共同形成收容空间，用来放置药物。其中，第一连接件10、第二连接件20、第三连接件30的厚度、各个底面的宽度可根据传送的药物尺寸来调整。
若药品体积较小时，则只采用第一连接件10和第二连接件20形成收容空间，用来放置药物。若形成的收容空间可以同时放置两支药物时，则需要在第一连接件10和第二连接件20的开口处设置垫圈，进而减小收容空间，避免用户同时放置两支药品于一个收容空间中。
如图5所示，为药物传送装置的模块图。
一种药物传送装置，包括上述药物传送结构200、用于提供驱动力的源驱动模块502、主驱动模块503及外壳501；
所述源驱动模块502的驱动力传导给所述主驱动模块503；所述主驱动模块503用于驱动所述药物传送结构200绕所述主驱动模块503转动；所述药物传送结构200转动的时候，带动置于所述药物传送结构200中的药物运动；所述外壳501用于收容所述源驱动模块502、所述主驱动模块503及所述药物传送结构200；所述外壳501还设有药物出口。
在本实施例中，所述源驱动模块502包括电机5021和第一转轮5022，所述电机5021与所述第一转轮5022固定连接，所述电机5021转动的时候带动所述第一转轮5022转动。
电机5021的转轴与第一转轮5022的轴心固定连接，电机5021转动过程中，带动第一转轮5022转动。因此，第一转轮5022通过齿轮传动带动与其连接的其他的转轮转动。
所述主驱动模块503包括第三转轮5032、第一转轴5033及第一链轮5031。
请结合图6。所述第一转轴5033穿设于所述第一链轮5031中，所述第一转轴5033的一自由端与所述第三转轮5032的轴心固定连接、另一自由端收容于所述外壳501中；所述第三转轮5032转动的时候带动所述第一转轴5033转动，进而带动所述第一链轮5031转动。
在不使用传动模块505的情况下，第一转轮5022与第三转轮5032直接齿接，在第一转轮5022转动时，能够带动第三转轮5032转动。第三转轮5032的轴心与第一转轴5033固定连接，同时，第一转轴5033与第一链轮5031固定连接。因此，第三转轮5032转动时，会带动第一转轴5033、第一链轮5031同时转动。
第一链轮5031的齿槽、轮齿排布与药物传送结构200中的第一连接柱103、第一短底面102、第二连 接柱、第二短底面202吻合。即第一连接柱103和第二连接柱203落入第一链轮5031的齿槽中，第一链轮5031的轮齿则落入第一短底面102及第二短底面202中。若药物传送结构200中增加了第三连接件30。则第一链轮5031的轮齿会分别落入第一短底面102及第二短底面202、第三长底面301中。
在本实施例中，第一转轴5033沿径向做了切边，使得第一转轴5033与第一链轮5031之间不会产生相对位移。
请结合图6。在本实施例中，药物传送装置还包括分别连接所述源驱动模块502与所述主动驱动模块的传动模块505；所述传动模块505用于将所述源驱动模块502的驱动力传导给所述主驱动模块503。
所述传动模块505包括第二转轮，所述第二转轮与所述源驱动模块502连接，所述源驱动模块502转动时驱动所述第二转轮转动。
请结合图7。药物传送装置还包括从驱动模块506，所述从驱动模块506与所述主驱动模块503相对设置，使所述药物传送结构200同时绕所述主驱动模块503及所述从驱动模块506转动。
从驱动模块506包括第二转轴5063及第二链轮5061。所述第二转轴5063穿设于所述第二链轮5061中，所述第二转轴5063的一自由端收容于所述外壳501中；所述第一链轮5031转动时带动所述第一转轴5033转动。
在本实施例中，从驱动模块506还包括套筒5062、弹簧件5064及固定件5065。套筒5062分别套设于第二转轴5063的两自由端上，套筒5062沿径向延伸的自由端与固定件5065连接。弹簧件5064套设于套筒5062的自由端上。在从驱动模块506转动过程中，沿径向产生拉力时，套筒5062及弹簧件5064产生形变来抵消拉力。在从驱动模块506转动过程中沿径向产生压力时，套筒5062及弹簧件5064产生形变来抵消压力。因此，能够使药物传送结构200紧绷的绕主驱动模块503及从驱动模块506转动。
请结合图8。
源驱动模块502、传动模块505及主驱动模块503依次排布于药物传送结构200形成的中空位置中，其中，主驱动模块503的第一链轮5031与药物传送结构200贴合。由于第一连接的齿槽和轮齿的排布与药物传送结构200的第一连接柱103、第二连接柱、第一短底面102和第二短底面202完全吻合，因此，在主驱动模块503转动的时候，能够带动药物传送结构200饶主驱动模块503转动。
为了药物传送结构200转动的更稳定，在药物传送结构200的另一端设置了从驱动模块506。其中，从驱动模块506的第二链轮5061在结构上与第一链轮5031完全一致。因此，第二链轮5061也能够带动药物传送结构200饶主驱动模块503转动。
请结合图8和图9。所述外壳501包括收容槽、顶盖；所述收容槽用于收容所述源驱动模块502、所述主驱动模块503及所述药物传送结构200，所述收容槽还设置有所述药物出口；所述收容槽开口的一面与所述顶盖活动连接。
药物传送装置还包括第一底盖(图未示)和第二底盖(图未示)，所述第一底盖(图未示)和所述第二底盖(图未示)分别覆盖于所述药物传送结构200绕所述主驱动模块503转动时、形成的两侧面。
基于上述所有实施例，源驱动模块502提供驱动力，带动传动模块505，使传动模块505将驱动力传导给主驱动模块503，因而，主驱动模块503能够带动药物传送结构200饶主驱动模块503转动。同时，设置从驱动模块506，使得药物传送结构200能够更加稳定的饶主驱动模块503及从驱动模块506转动。外壳501收容药物传送结构200、源驱动模块502、传动模块505、主驱动模块503、从驱动模块506后，将药物放置于药物传送结构200的收容空间内，每个收容空间中只能存放一支药品。因此，在药物传送结构200转动过程中，会带动药物一起运动，需要取药的时候，控制药物传送结构200运动到特定位置，且使药物运行到外壳501的开口处，进而药物能够自动掉落，实现单支取药的功能。
在其他实施例中，可以不使用传动模块和/或从驱动模块506。同样也能够实现单支药物管控的功能。
采用上述药物传送装置，能够对单支药品进行管控。药物传送结构200的每个收容空间中放置一支药品，且收容空间的大小可以根据药品的体积大小进行调整，使其能够刚好容纳单支药品。相比传统的单支药品管控结构来讲，上述药物传送装置的结构更为简便，且能够根据管控药品的体积来调整收容空间，无需改变主体结构，在原有基础上增加或减少垫圈就能够实现兼容多种规格的药品。
上述药物传送装置通过源驱动模块502提供驱动力，使主驱动模块503转动，进而主驱动模块503带动药物传送结构200运动，置于药物传送结构200中的药物则能跟随药物传送结构200运动，使用外壳501收容源驱动模块502、主驱动模块503及药物传送结构200，能够避免药物在传送过程中散落，进而实现药物传送。相比传统的药物传送装置来说，减少了元器件，进而降低产品成本。
应当理解，即使上述实施例中是由源驱动模块502、传动模块505以及主驱动模块503驱动药物传送结构200运动的，即是，源驱动模块502通过一传动模块505及主驱动模块503间接地驱动药物传送结构200运动，但本申请并不局限于此；在本申请的其他实施例中，还可以仅包括源驱动模块。例如，在一些实施例中，源驱动模块包括电机与上述第一链轮，该第一链轮安装于电机的输出端，其亦可以实现上述方案。
在一些实施例中，上述药物传送装置还包括用于限缩上述收容空间的限位组件40。上述药物传送机构1000围成一环形空间；该限位组件40安装于收容槽5011的内壁，并环绕上述环形空间延伸呈非封闭的C形，该限位组件40非封闭的两端之间形成一面向上述药物出口设置的开口。相应地，第一长底面101与第二长底面201背离环形空间的一侧均设有收容上述限位组件40的至少部分的避位切口，以在所述药物传送结构200运动的过程中，避免第一连接件10与限位组件40干涉，以及避免第二连接件20与限位组件40干涉。限位组件40的设置可限缩上述收容空间的尺寸，以使该药物传送装置适用于存储小体积的药品。具体地，请参阅图10与图11，其分别示出了本申请其中一实施例提供的药物传送装置隐藏顶盖后的立体示意图以及分解示意图；上述外壳501包括收容槽5011与顶盖5012。收容槽5011具体包括底板50111和环形板50112，底板50111为平板状，底板50111连接于环形板50112的一端。底板50111与环形板50112围合形成一收纳槽，收纳槽背离底板50111的一面设有开口；顶盖5012盖合于该开口处。限位组件40则收容于上述收纳槽内。
请一并参阅图12至图14，其分别示出了收容槽5011的三个方向的立体示意图，同时结合其他附图，环形板50112包括第一弧形部501121、第二弧形部501122、第一平板部501123以及第二平板部501124。第一弧形部501121和第二弧形部501122相对设置，第一平板部501123和第二平板部501124相对设置，第一弧形部501121、第一平板部501123、第二弧形部501122以及第二平板部501124依次连接并围合。第一弧形部501121上设有药物出口1009，药物出口1009将收纳槽与外部连通，药物出口1009用于取出药物传送结构200上的药物。环形板50112的内壁上设有至少一个沿第一方向X延伸的限位槽，该限位槽背离底板的一端贯通环形板50112；上述限位组件40的边缘设有至少一组限位块，限位块的形状与限位槽相适配，每一组限位块对应插入限位槽内，以使限位块与限位槽共同配合而对限位组件进行定位。此外，限位槽内设有还限位柱，环形板50112的内壁上还设有卡槽，该限位柱与卡槽用于对限位组件40进行沿第一方向X上的定位安装。
具体地，上述至少一限位槽包括第一限位槽1001、第二限位槽1002以及第三限位槽1003，该第一限位槽、第二限位槽1002以及第三限位槽1003分别自环形板50112沿第一方向X延伸。其中，第一限位槽1001设于第一弧形部501121与第一平板部501123连接处，第二限位槽1002设于第一弧形部501121与第二平板部501124连接处，第三限位槽1003设于第二弧形部501122上。其中，第一方向X为底板50111朝向收纳槽开口的方向。
限位柱亦为至少一个，本实施例中，该至少一个限位柱包括第一限位柱1004、第二限位柱1005以及 第三限位柱1006，第一限位柱1004、第二限位柱1005以及第三限位柱1006分别自底板50111沿第一方向X延伸，且第一限位柱1004、第二限位柱1005以及第三限位柱1006的延伸高度相同。第一限位柱1004设于第一限位槽1001内，第二限位柱1005设于第二限位槽1002内，第三限位柱1006设于第三限位槽1003内。其中，第三限位柱1006的数量为两个，两个第三限位柱1006分别设于第三限位槽1003的两侧。
卡槽包括第一卡槽1007和第二卡槽1008，第一卡槽1007和第二卡槽1008分别自环形板50112的内壁凹陷。第一卡槽1007和第二卡槽1008分别设于第一弧形部501121的两侧，其中，第一卡槽1007设于第一弧形部501121朝向第一平板部501123的一侧，第二卡槽1008设于第一弧形部501121朝向第二平板部501124的一侧。
请一并参阅图14至图16，每个第一连接件10或者每个第二连接件20上分别设有两个避位切口，两个避位切口的形状呈U型。两个避位切口分别为第一避位切口和第二避位切口，第一避位切口和第二避位切口沿第一方向X并排分布，第一避位切口和第二避位切口用于避让限位组件40。
每个第一长底面101远离第一短底面102的一侧，即是背离环形空间的一侧设置有第一避位切口1011和第二避位切口1012，第一避位切口1011和第二避位切口1012沿第一方向X并排分布。第一避位切口1011靠近第一长底面101朝向底板50111的一端，第二避位切口1012靠近第一长底面101朝向收纳槽开口的一端。每个第二长底面201远离第二短底面202的一侧设置有第一避位切口2011和第二避位切口2012，第一避位切口2011和第二避位切口2012沿第一方向X并排分布。第一避位切口2012靠近第二长底面201朝向底板50111的一端，第二避位切口2012靠近第二长底面201朝向收纳槽开口的一端。在本实施例中，第一连接件10的第一避位切口1011和第二连接件20上的第一避位切口2011的形状相同；各第一避位切口(第一避位切口1011与第一避位切口2011)共同环绕呈一与药物传送结构200形状相似的椭圆状切口。第一连接件10的第二避位切口1012和第二连接件20上的第二避位切口2012的形状相同；各第二避位切口(第二避位切口1012与第二避位切口2012)共同围绕呈一环绕上述环形空间的椭圆形切口。
请复参阅图11，限位组件40包括第一限位件41和第二限位件42，第一限位件41和第二限位件42分别安装于环形板50112的内壁。第一限位件41的一端和第二限位件42的一端连接，第一限位件41和第二限位件42形成非封闭的C形，该非封闭C形形状与环形板50112的内壁形状相适配，该非封闭环状的开口的位置与药物出口1009的位置相对应。
请一并参阅图17至图19，第一限位件41设有第一头端4101和第一尾端4102，第一头端4101为第一限位件41朝向第一弧形部501121的一端，第一尾端4102为第一限位件41背离第一弧形部501121的一端，其位于第二弧形部501122处。第二限位件42设有第二头端4201和第二尾端4202，第二头端4201为第二限位件42朝向第一弧形部501121的一端，第二尾端4202为第二限位件42背离第一弧形部501121的一端，其位于第二弧形部501122处。其中，第一尾端4102与第二尾端4202连接，第一头端4101与第二头端4201之间具有间隙，从而形成上述与药物出口1009对应的开口。
第一限位件41包括第一骨位部410和第一连接部412，第一骨位部410的数量为两个，两个第一骨位部410沿第一方向X连接于第一连接部412的两端。第一骨位部410和第一连接部412分别自第一头端4101呈弧状延伸至第一尾端4102，两个第一骨位部410和第一连接部412的一面分别抵接第一弧形部501121、第一平板部501123以及第二弧形部501122。两个第一骨位部410的另一面分别相对于第一连接部412凸起，其中一个第一骨位部410位于第一连接件10和第二连接件20的第一避位切口内，另一个第一骨位部410位于第一连接件10和第二连接件20的第二避位切口内。第二限位件42包括第二骨位部420和第二连接部422，第二骨位部420的数量为两个，两个第二骨位部420沿第一方向X连接于第二连接部422的两端。第二骨位部420和第二连接部422分别自第二头端4201呈弧状延伸至第二尾端4202，两个第二骨位部420和第二连接部422的一面分别抵接第二弧形部121、第二平板部123以及第二弧形部501122。两个 第二骨位部420的另一面分别相对于第二连接部422凸起，其中一个第二骨位部420位于第一连接件10和第二连接件20的第一避位切口内，另一个第二骨位部420位于第一连接件10和第二连接件20的第二避位切口内。综上所述，第一骨位部410和第二骨位部420分别穿设于第一避位切口和第二避位切口内，可以减小第一连接件10和第二连接件20之间收容空间的体积，以使得便于存储小体积的药品。
可以理解的是，在一些其他实施例中，第一骨位部410和第二骨位部420的数量可以根据实际需求增加或减少，比如分别设置为一个、三个等，只需能满足使用需求即可。可以理解的是，在一些其他实施例中，第一骨位部410相对于第一连接部412的凸起高度可以根据实际需求设置，第二骨位部420相对于第二连接部422的凸起高度可以根据实际需求设置，以满足不同体积的药品的存储需求。
第一限位件41的第一头端4101处设有第一限位块414，第一限位块414的数量为两个，两个第一限位块414分别沿第一方向X分布于两个第一骨位部410上。两个第一限位块414分别设于两个第一骨位部410朝向环形板50112内壁的一面，且每个第一限位块414自对应的一个第一骨位部410朝向背离收纳槽的方向凸起。两个第一限位块414分别卡设于第一限位槽1001中，其中，朝向底板50111的一个第一限位块414抵接第一限位柱1004。可以理解的是，在一些其他实施例中，第一限位块414的数量可以根据实际需求增加或减少，比如设置为一个、三个、四个等，只需第一限位块414的数量为至少一个即可，且至少一个第一限位块414抵接第一限位柱1004。第二限位件42的第二头端4201处设有第二限位块424，第二限位块424的数量为两个，两个第二限位块424分别沿第一方向X分布于两个第二骨位部420上。两个第二限位块424分别设于两个第二骨位部420朝向环形板50112内壁的一面，且每个第二限位块424自对应的一个第二骨位部420朝向背离收纳槽的方向凸起。两个第二限位块424分别卡设于第二限位槽1002中，其中，朝向底板50111的一个第二限位块424抵接第二限位柱1204。可以理解的是，在一些其他实施例中，第二限位块424可以根据实际需求增加或减少，比如设置为一个、三个、四个等，只需第二限位块424的数量为至少一个即可，且至少一个第二限位块424抵接第二限位柱1205。
第一限位件41的第一尾端4102与第二限位件42的第二尾端4202固定连接。具体地，第一尾端4102处设有两第一拼接块416，两个第一拼接块416分别沿第一方向X分布于两个第一骨位部410上。该两个第一拼接块416分别设于两个第一骨位部410朝向环形板50112内壁的一面，且每个第一拼接块416自对应的一个第一骨位部410朝向背离收纳槽的方向凸起。两个第一拼接块416分别卡设于第三限位槽1003中，其中，朝向底板50111的一个第一拼接块416抵接第三限位柱1006。第三限位柱1006第二尾端4202处设有两第二拼接块426，该两个第二拼接块426分别沿第一方向X分布于两个第二骨位部420上。两个第二拼接块426分别设于两个第二骨位部420朝向环形板50112内壁的一面，且每个第二拼接块426自对应的一个第二骨位部420朝向背离收纳槽的方向凸起。两个第二拼接块426分别卡设于第三限位槽1003中，其中，朝向底板50111的一个第二拼接块426抵接第三限位柱1006。第三限位柱1006第一限位件41与第二限位件42连接时，每个第一拼接块416和对应的一个第二拼接块426可拼接形成第三限位块。第三限位块的形状与第三限位槽1003的形状相适配，第三限位块卡设于第三限位槽1003内。靠近底板的第一拼接块416抵接第三限位槽1003内的其中一个第三限位柱1006，靠近底板的第二拼接块426抵接第三限位槽1003内的另一个第三限位柱1006。
第一尾端4102处还设有两连接轴418，该两个连接轴418分别沿第一方向X分布于两个第一骨位部410上。两个连接轴418分别设于两个第一骨位部410朝向环形板50112内壁的一面，且每个连接轴418自对应的一个第一骨位部410朝向背离收纳槽的方向凸起。第二尾端4202处还设有两连接块428，该两个连接块428分别设于两个第二骨位部420朝向环形板50112内壁的一面。两个连接块428分别沿第一方向X分布于两个第二骨位部420上，每个连接块428的位置与一个连接轴418的位置相对应。每个连接块428设置有连接通孔，每个连接轴418插设于对应的一个连接通孔内，以使得第一限位件41和第二限位件42 之间连接固定。可以理解的是，在一些其他实施例中，连接轴418何连接块428的数量分别可以根据实际需求增加或减少，比如分别设置一个、三个等，只需满足第一限位件41和第二限位件42之间的连接强度即可。
可以理解的是，在一些其他实施例中，第一限位件41和第二限位件42之间也可以设置其他连接结构，比如螺接、卡接、铆接、粘接等，或者，第一限位件41和第二限位件42也可以一体成型，在此不予限定。
第一限位件41的第一头端4101处还设有第一卡块419，第一卡块419设于第一连接部412朝向环形板50112内壁的一面。第一卡块419自第一连接部412朝向背离收纳槽的方向凸起，第一卡块419卡设于第一卡槽1007内，以使得第一限位件41固定于收容槽5011。即是，上述第一限位块414、第一限位槽1001、该第一卡块419、该第一卡槽1007以及第一限位柱1004共同配合使第一限位件41固定于收容槽5011。较优地，第一卡块419朝向底板50111的一面设置为斜面，第一限位件41与收容槽5011装配时，该斜面可使得第一卡块419能更好的滑入第一卡槽1007内。
第二限位件42的第二头端4201处还设有第二卡块429，第二卡块429设于第二连接部422朝向环形板50112内壁的一面。第二卡块429自第二连接部422朝向背离收纳槽的方向凸起，第二卡块429卡设于第二卡槽1008内，以使得第二限位件42固定于收容槽5011。即是，上述第二限位块424、第二限位槽1002、该第二卡块429、该第二卡槽1008以及第二限位柱1005共同配合使第二限位件42固定于收容槽5011。较优地，第二卡块429朝向底板50111的一面设置为斜面，第二限位件42与收容槽5011装配时，该斜面可使得第二卡块429能更好的滑入第二卡槽1008内。
请参阅图20至图22，本申请另一实施例提供一种药物传送机构1000，包括底座1200、连接组件1300以及上述任一实施例中的药物传送装置1100。底座1200和药物传送装置1100之间通过连接组件1300可拆卸地连接。
药物传送装置1100的收容槽5011还包括固定板50113，固定板50113设于环形板50112的外壁。固定板50113呈L型板状结构，固定板50113与环形板50112之间设有安装空间，连接组件1300安装于安装空间内。固定板50113包括固定部501131和弯折部501132，固定部501131与弯折部501132连接，且固定部501131与弯折部501132之间大致呈直角设置。固定板50113位于环形板50112远离药物出口1009的一端，固定部501131通过紧固件固定于第一平板部501123上，弯折部501132自固定部501131延伸至与第二弧形部501122连接。
固定板50113上设有两个限位通槽501133，两个限位通槽501133分别将安装空间与外部连通。两个限位通槽501133分别设于固定部501131上，两个限位通槽501133沿第一方向X并排分布。沿第一方向X，两个限位通槽501133相互背离的一端分别设有第一抵接壁，两个限位通槽501133相互朝向的一端分别设有第二抵接壁。
收容槽5011还包括两个延伸板50114，该两个延伸板50114分别由收容槽5011沿第一方向X相对的两表面向外延伸形成延伸板50114。固定板50113设于两个延伸板50114之间，固定板50113的两端分别与两延伸板50114连接。每个延伸板50114上设有避让孔501141，两个避让孔501141分别将安装空间与外部连通。
收容槽5011还包括两个安装块501125，安装块501125位于安装空间内，安装块501125固定于第二弧形部501122上。安装块501125内设有安装槽，安装槽背离第二弧形部501122的一端设有开口。两个安装块501125沿第一方向X相互背离的一端分别设置有连通槽，连通槽连通安装槽和安装空间。
底座1200设有一面开口的容纳槽，容纳槽的形状与药物传送装置1100的形状相适配，药物传送装置1100收容于容纳槽内。底座1200的两个侧壁上分别设有两个卡接槽1201，卡接槽1201将容纳槽与外部连通。当药物传送装置1100安装于容纳槽内时，每个卡接槽1201分别与对应的一个避让孔501141连通。
请参阅图23和图24，连接组件1300包括两卡接件1310与两弹性件1320。卡接件1310安装于收容槽5011外壁朝向容纳槽开口的一侧，并与收容槽5011之间沿第一方向X滑动配合，两卡接件1310之间沿第一方向X相对设置。卡接件1310背离另一卡接件1310的一侧设有卡接部1312，底座1200的内壁于对应卡接部1312处设有卡接槽1201；卡接件1310可于锁止位置与解锁位置之间运动，其中，于锁止位置，卡接部1312插入卡接槽1201；于解锁位置，卡接部1312退出卡接槽1201。弹性件1320与卡接件1310一一对应，两弹性件1320设于两卡接件1310之间，弹性件1320的一端与卡接件1310抵接，另一端与收容槽5011抵接。值得一提的是，本申请文件中所述的“滑动配合”是指相互配合连接的两部件之间，一部件可相对另一部件沿特定方向滑动。
具体地，卡接件1310包括基部1311、卡接部1312以及把手部1313，卡接部1312和把手部1313分别连接于基部1311。其中，基部1311位于上述两延伸板之间，其包括基板13111、连接板13112与抵接板13113。基板13111与上述固定板50113相适配，其与固定板50113朝向收容空间的一面接触，基部1311可沿固定板50113的内壁移动沿第一方向X移动；连接板13112设于基部1311背离另一卡接件1310的一侧，其连接基板13111相互弯折的两部分；抵接板13113的一端固定于连接板13112，另一端沿第一方向X朝向另一卡接件1310延伸，其穿过上述连通槽。卡接部714设于基部1311背离另一卡接件1310的一侧，其具体与连接部固定；上述延伸板于对应卡接部处设有供卡接部穿过的避让孔。弹性件1320收容于上述安装槽内，其处于压缩状态，其一端与安装槽背离抵接板13113的内壁面抵接，另一端与抵接板13113抵接。当卡接件1310位于锁止位置时，基部1311分别与弹性件1320及延伸板抵接，卡接部1312部分穿过避让孔，进而使卡接件1310可伸入至上述卡接槽，从而使药物传送装置1100与底座1200固定连接；当卡接件1310位于解锁位置时，卡接件1310进一步压缩弹性件1320，进而使卡接件1310可退出上述卡接槽，从而使工作人员可将药物传送装置1100自底座1200中取出。
把手部1313自基部1311延伸出限位通槽501133，其用于供工作人员施加压力，而使卡接件1310自上述锁止位置运动至解锁位置；当然，把手部1313也便于工作人员提握该药物传送装置。本实施例中，把手部包括第一部分与第二部分。第一部分与上述容纳槽的开口截面轮廓平行设置，第二部分与第一部分垂直设置，该第一部分与第二部分均与上述第一方向X垂直。其中，第一部分便于药物传送装置1100卧式状态地收容于容纳槽时，工作人员顺畅地将其自容纳槽中取出。第二部分便于药物传送装置1100立式状态地收容于容纳槽时，即上述第二弧形部朝向容纳槽开口，药物传送装置1100的其余部位被容纳槽的壁面包裹时，供工作人员顺畅地将其自容纳槽中取出。
在一些实施例中，为使药物传送结构200能够有序地行进设定距离的整数倍，从而使每一收容空间内的药品均能够有序的运动至上述药物出口处，该药物传送机构还包括光电传感器与控制器；其中，上述设定位移为相邻两收容空间之间的距离。请参阅图25至图30，其分别示出了本申请其中一实施例提供的药物传送机构1000的立体示意图、一个方向的剖切示意图、分解示意图，以及药物传送装置的分解示意图、药物传送装置隐藏外壳后的两个方向的立体示意图，同时结合其他附图，该药物传送机构1000包括药物传送装置1100、底座1200、光电传感器1400以及控制器1500。
具体地，该药物传送结构200围成一环形空间201，上述第一连接件10或第二连接件20面向该环形空间201的一侧设有挡光片204，一挡光片204对应一上述收容空间202。本实施例中，第二连接件20设有上述挡光片204，该挡光片204自第二短底面202朝向环形空间201延伸。挡光片204为薄片状，为加强挡光片204的强度，第二连接件20面向环形空间201的一侧还设有与挡光片204连接的挡光片2041。
对于前述光电传感器1400，该光电传感器1400收容于上述环形空间201，其包括发射器1410与接收器1420，该发射器1410与接收器1420沿第一方向X间隔设置。沿第一方向X，上述挡光片204的位置位于发射器1410与接收器1420之间。挡光片204用于在药物传送结构200运动的过程中伸入发射器1410 与接收器1420之间，以遮挡发射器1410，即是阻止接收器1420接收发射器1410发射的光信号；光电传感器1400用于在药物传送结构200单向运动的过程中，测量发射器1410被挡光片204遮挡的次数。由于每一第二连接件20均具有挡光片204，该挡光片204与收容空间202一一对应，则药物传送结构200每行进单位的设定位移(相邻两收容空间之间的距离)，一挡光片204遮挡光电传感器1400的发射器一次，光电传感器1400计数一次。
对于上述控制器1500，请参阅图27，其安装于底座1200，并分别与源驱动模块502、光电传感器1400连接，进而可有序地控制源驱动模块502适时运行，以使药物传送结构200整数倍的设定位移。具体来说，本药物传送机构1000可以通过光电传感器1400监控药物传送结构200是否行进了设定位移的整数倍；控制器根据光电传感器1400倍遮挡的次数而精准地控制源驱动模块502适时运行，使各收容空间202内的药品均能够有序运动至药物出口1009处实现掉料。
在工作人员向药物传送装置1100内补充药品后，药柜系统需要对药物传动装置中的各收容空间202内是否收纳有药品进行盘点。一般地，盘点过程是通过上述源驱动模块502驱动药物传送机构1000运行一整圈，相应的传感器探测各收容空间202内是否具有药品。在盘点过程进行之前需要将药物传送结构200驱动至一特定的预设位置，从而可将每次盘点的基准设定为统一，但目前药物传送机构1000的结构无法检测药物传送结构200是否运动至了上述预设位置，从而无法稳定地进行盘点过程。为克服上述不足，本申请实施例提供的药物传送机构还包括磁体1600与霍尔元件1610。
对于前述磁体1600，请参阅图26与图27，其中，磁体1600安装于药物传送结构200。本实施例中，其具体收容于一收容空间202内，并靠近于收容槽5011的底板设置。
对于前述霍尔元件1610，请继续参阅图26与图27，其安装底座1200，并靠近药物传送结构200设置。本实施例中，霍尔元件1610靠近收容槽5011的底板设置，且与上述磁体1600分别设于该底板的两侧。霍尔元件1610用于与磁体1600共同配合，以检测药物传送结构200是否运动至预设位置。具体地说，当药物传送结构200运动至上述预设位置时，磁体1600随其运动至霍尔元件1610处；此时，霍尔元件1610会向控制器1500发送一电平变化的信号，控制器1500在获取该信号之后即控制源驱动模块502停止运行，使药物传送结构200维持在该预设位置。控制器1500可获取药物传送结构200此时的位置，并将其设定为“零位”，以作为盘点药品过程中的基准，以及控制各收容空间202中的药品运动至上述药物出口1009处的基准。值得一提的是，当药物传送结构200位于上述预设位置时，一收容空间202恰好对准上述药物出口1009。
进一步地，考虑到霍尔元件1610的精度较低，为使药物传送结构200的回零过程更为精准，该药物传送机构1000还包括与控制器1500连接的光电开关1620。具体地，请参阅图29并结合其他附图，光电开关1620与上述光电传感器1400的结构实质相同，其收容于上述环形空间201内，并具体包括光发射器1621与光接收器1622。沿上述第一方向X，该光发射器1621与光接收器1622间隔设置；上述各挡光片204中的其中一个用于在磁体1600靠近霍尔元件1610的过程中伸入光发射器1621与光接收器1622之间，以遮挡光光发射器1621，以使该磁体1600、霍尔元件1610、一挡光片204以及光电开关1620共同配合检测药物传送结构200是否运动至上述预设位置。具体地，在霍尔元件1610感应到磁体1600后，光电开关1620的光发射器1621首次被遮挡时，即是药物传送结构200行进至预设位置。由于仅依靠霍尔元件1610确定预设位置的精度较低，仅依靠霍尔元件1610难以实现精确对定位；而挡光片204的数量较多，仅依靠挡光片204确定预设位置又难以实现；本实施例中，通过结合该霍尔元件1610与光电开关1620同时确定预设位置的方案精准可靠。
进一步地，为实现盘点各收容空间202中是否存在药品，该药物传送机构1000还包括与上述控制器1500连接的激光器1700。具体地，请参阅图27，激光器1700包括发射端1710与接收端1720。沿上述第 一方向X，发射端1710与接收端1720分别设于药物传送结构200的两侧，并分别安装于底座1200；发射端1710发射的激光可穿过收容空间202，并由接收端1720接收。在药物传送结构200运动至上述预设位置时，收容有磁体1600的收容空间与激光器1700的光路对应，即发射端1710发射的激光穿过收容有磁体1600的收容空间202。一般地，收容有磁体1600的收容空间202是不用来收容药品的，则原则上在药物传送结构200回零后，接收端1720接收的激光的强度是一致或基本一致的；当接收端1720接收的光强发生明显变化时，控制器可通过未示出的输出模块(如显示器、音箱等)提示工作人员校正激光器1700输出激光的强度。
更进一步地，该药物传送机构还包括反射镜1730，反射镜1730安装于底座1200并用于反射上述发射端1710发射的激光，从而使发射端1710可平行地安装于底座1200面向上述顶盖5012的壁面上，进而减小药物传送机构1000占用的整体体积；同时也便于将发射端1710发射的激光调整至落在接收端1720上，以避免发射端1710及接收端1720安装误差导致接收端1720不能顺利接收激光的弊端。具体地，反射镜1730包括镜体1731与镜柄1732。其中，镜体1731用于反射发射端1710发射的激光。镜柄1732的一端与镜体1731固定，另一端远离镜体1731延伸；底座1200设有与镜柄1732形状适配的安装孔，镜柄1732过盈地安装于该底座1200的安装孔。较优地，为便于工作人员在装配激光器1700与反射镜1730的过程中，可方便地调节反射镜1730的角度，从而准确地将发射端1710发射的激光反射至接收端1720处，镜柄1732还设有插孔。工作人员可通过将一销轴插入该插孔，然后通过掰动该销轴以方便地转动镜柄1732。可选地，该插孔设于镜柄1732远离镜体1731的一端，其轴线与镜柄1732的延伸方向垂直。可以理解的是，在本申请的其他实施例中，插孔亦可以是自镜柄1732远离镜体1731的一端起始，平行于镜柄1732延伸；此时，采用一L形的杆件即可实现转动镜柄1732的目的。
底座1200在对应上述药物出口1009的位置设有一药物通槽1202，药品可依次经由该药物出口1009及药物通槽1202掉落至药物传送机构1000之外。若药物通槽1202一直处于与药物传送机构1000的外界连通的状态，医护人员只能依次自最靠近药物出口1009的收容空间202向远离该药物出口1009的收容空间202依次取出药品，而不能直接取出期望位置的药品，同时不取出药物出口1009与期望位置之间的药品。为克服上述不足，本申请实施例提供的药物传送机构1000还包括闸门1800以及驱动组件1900。驱动组件1900分别与闸门1800及上述控制器1500连接，其用于驱动闸门1800于打开位置和关闭位置运动。其中，于打开位置，闸门1800打开上述药物通槽1202，药物通槽1202连通药物出口1009与药物传送机构1000的外部环境；于关闭位置，闸门1800封堵上述药物通槽1202。
请参阅图31，其示出了该药物传送机构1000的分解示意图，底座1200包括底部板1210、第一侧板1220、第二侧板1230、前端板1240以及后端板1250，底部板1210、第一侧板1220、第二侧板1230、前端板1240以及后端板1250均可拆卸连接，以围合成容纳槽，前端板1240设有药物通槽1202。其中，前端板1240面向上述药物出口1009，并设有上述药物通槽。闸门1800可滑动地安装于前端板1240，且闸门1800可在打开位置与关闭位置之间滑动。
请再参阅图32至图34，其分别示出了前端板1240、闸门1800与驱动组件1900的连接示意图，闸门1800与驱动组件1900的分解示意图，以及闸门1800的立体示意图，同时结合其他附图，前端板1240面向药物传送装置1100的一面设有沿预设方向延伸的凸条1241，相应地，闸门1800面向凸条1241的一侧设有与凸条1241相适配的滑槽1810。上述凸条1241插入滑槽1810，以使闸门1800与底座1200之间沿上述预设方向滑动配合。可选地，凸条1241沿垂直于底部板1210的方向延伸。进一步可选地，凸条1241的数量为两个，该两凸条1241分别设有药物通槽的两侧；相应地，滑槽1810的数量亦为两个，一滑槽对应一凸条1241。
驱动组件1900包括驱动电机1910、齿轮1920以及齿条1930。其中，驱动电机1910安装于底座1200， 并与上述控制器1500连接。齿轮1920固定于驱动电机1910的输出轴。齿条1930固定于闸门1800，并沿平行于上述凸条1241的方向延伸，该齿条1930与齿轮1920啮合。则，该药物传送机构1000可通过驱动电机1910驱动齿轮1920周转，进而带动齿条1930及闸门1800于上述打开位置与关闭位置之间滑动。通常，闸门1800处于关闭位置；当期望取出的药品在上述药物传送结构200的带动下运动至药物通槽1202处时，控制器1500则控制驱动电机1910运行，以使闸门1800运动至打开位置。当药品取出之后，控制器1500再控制驱动电机1910反向运行，使闸门1800运动至关闭位置。较优地，齿条1930与闸门1800一体成型；更优地，齿条1930与闸门1800通过注塑一体成型。可以理解的是，在本申请的其他实施例中，齿条1930与闸门1800亦可以是分体设置，然后通过螺接、卡接、焊接或其他工艺固定。
进一步地，为使闸门1800可精准的在打开位置与关闭位置之间运动，药物传送机构1000还包括第一感应件1940与第二感应件1950。具体地，请参阅图33，第一感应件1940及第二感应件1950均与控制器1500连接，第一感应件1940用于检测闸门1800是否运动至打开位置，第二感应件1950用于检测闸门1800是否运动至关闭位置。闸门1800具有遮挡条1820，当遮挡条1820运动至第一感应件1940处时，闸门1800位于打开位置；第一感应件1940检测闸门1800到达打开位置，控制器控制驱动电机1910停止运行，以使药品可顺利掉落出药物传送机构1000。当遮挡条1820运动至第二感应件1950处时，闸门1800位于关闭位置，以阻止药品通过掉落出药物传送机构1000。可选地，第一感应件1940以及第二感应件1950均为光电传感器；当遮挡条1820运动至第一感应件1940处时，其伸入第一感应件1940的发射器与接收器之间；当遮挡条运动至第二感应件1950处时，其伸入第二感应件1950的发射器与接收器之间。
请参阅图35，其示出了本申请其中一实施例提供的药柜9000，该药柜9000呈抽柜式结构，其包括柜架5000以及多个抽屉单元4000。柜架5000设有收纳空间；抽屉单元4000可滑动地安装于柜架5000，并可伸出或缩回至收纳空间；各抽屉单元4000如图自上而下依次设置，以形成具有多层抽屉单元4000的药柜9000。值得一提的是，本申请中的“多个”意为两个以上。当然，在本申请的其他实施例中，抽屉单元4000的数量亦可以是仅一个。
请参阅图36至图38，抽屉单元4000包括抽屉架4100、输送机构4200以及至少一药物传送机构组4300。其中，抽屉架4100可滑动地安装于上述柜架5000，并可于上述伸出位置与缩回位置之间运动，其设有容置腔，用以收容上述输送机构4200以及药物传送机构组4300。
对于抽屉架4100，其包括抽屉底板、第一抽屉侧板、第二抽屉侧板、朝向药柜9000的外部环境的抽屉前端板(未示出)以及收容于上述收纳空间并与抽屉前端板相对的抽屉后端板(未标示)，第一抽屉侧板、第二抽屉侧板、抽屉前端板以及抽屉后端板均与抽屉底板连接，以围合形成容置腔4110。
对于上述输送机构4200，请参阅图37与图38，其分别示出了抽屉单元4000隐藏抽屉架4100及药物传送机构组4300后的立体示意图，以及输送机构4200的立体示意图，输送机构4200用于接收上述药物传送机构组4300输送的药品。本实施例中，输送机构4200包括主动轮4210、从动轮4220、输送带4230以及动力组件4240。其中，主动轮4210与从动轮4220均可转动地安装于抽屉架4100，且两者沿图示水平的第二方向Y间隔设置；输送带4230呈分别的环状，其饶设于主动轮4210与从动轮4220。动力组件4240靠近上述抽屉后端板设置，其与主动轮4210连接，其用于驱动主动轮4210转动，以使输送带4230绕主动轮机从动轮4220转动，进而使输送带4230顶部的水平区域可运送药品行进，并将药品驱使至输送带4230靠近抽屉前端板的尽头。具体地，动力组件4240靠近上述抽屉后端板设置，其包括动力电机4241、第一齿轮4242与第二齿轮4243。动力电机4241固定安装于抽屉架4100，动力电机4241的输出轴与第一齿轮4242连接；第二齿轮4243与主动轮4210同轴固定，并且与第一齿轮4242啮合。当动力电机4241驱动第一齿轮4242转动时，第二齿轮4243将带动驱动轴转动，从而带动输送带4230运动。本实施例中，主动轮靠近抽屉后端板设置，从动轮靠近抽屉前端板设置，即是本实施例中的第二方向Y为抽屉后端板指 向抽屉前端板的方向。
对于上述药物传送机构组4300，请参阅图36，并结合其他附图，药物传送机构组4300包括相对设置的两上述药物传送机构1000，该两药物传送机构100沿垂直于第二方向Y的方向分设于输送带4230的两侧，且该两药物传送机构1000的药物出口1009彼此面向设置。如此，自药物传送机构1000送出的药品都将落在输送带4230上，从而输送带4230的带动下行进至输送带4230背离动力组件4400的一端，以供用户拿取。可选地，本实施例中，该抽屉单元4000包括多组药物传送机构组4300，该多组药物传送机构组4300沿上述第二方向Y间隔设置。
进一步地，输送机构4200还包括与抽屉架4100固定连接的隔板4250。该隔板4250设置于输送带4230的上方，并沿平行于输送带的方向延伸，其将输送带分隔成两个输送通道，每一输送通道用于输送与其临近的一列药物传送机构掉落的药品。通过设置隔板4250，每一列药物传送机构1000送出的药物可以单独沿着一输送通道运送输送带4230靠近抽屉前端板的一侧，可以确保两列药物传送机构1000的药物独立送出，避免混合。较佳地，为了防止隔板4250阻碍到输送带4230的运转，应保证隔板4250与输送带之间具有间隙，以避免其对输送带的行进造成摩擦阻力。
在一些实施例中，抽屉单元4000还包括靠近从动轮4220并用于接收输送机构4200输送的药品的承接台4400，以方便用户从该承接台4400取用药品。具体地，请参阅图37，同时结合其他附图，承接台4400为盒状结构，其收容于上述容置腔，并设于输送带靠近抽屉前端板的一端；承接台4400用于接收输送带运送至上述预设位置的药品。可选地，承接台4400的数量为两个，该两承接台4400并排设置，且与上述输送通道一一对应。较优地，为了防止药品自输送带直接掉落至承接台4400底部而导致药品损坏，承接台4400靠近输送带的一端设有一倾斜面，以使得药品经由该倾斜面滑至承接台底部。
进一步地，抽屉单元4000还包括与控制器1500连接的感应器4500。感应器4500安装于抽屉架4100并与承接台4400连接，其用于感应承接台4400是否承接有药品。在本实施例中，感应器4500为重量传感器；则当输送带4230输送的药品掉落至承接台4400时，承接台4400的重量将发生变化，由此可以根据承接台4400的重力变化判断是否有药物掉落。
本申请实施例提供的药柜9000包括柜架5000以及抽屉单元4000。其中，抽屉单元4000包括上述药物传送机构1000，故该药柜9000亦能够实现单支取药的功能。此外，抽屉单元4000包括抽屉架4100、输送机构4200以及若干药物传送机构1000；该若干药物传送机构1000统一规划陈列于抽屉架4100内，并且通过输送机构4200统一输送各药物传送机构1000送出的药品，能够避免针对每一药物传送机构1000单独设置一输送机构4200而导致占用空间大的弊端。
以上所述实施例的各技术特征可以进行任意的组合，为使描述简洁，未对上述实施例中的各个技术特征所有可能的组合都进行描述，然而，只要这些技术特征的组合不存在矛盾，都应当认为是本说明书记载的范围。
以上所述实施例仅表达了本申请的几种实施方式，其描述较为具体和详细，但并不能因此而理解为对申请专利范围的限制。应当指出的是，对于本领域的普通技术人员来说，在不脱离本申请构思的前提下，还可以做出若干变形和改进，这些都属于本申请的保护范围。因此，本申请专利的保护范围应以所附权利要求为准。

Claims (19)

  1. 一种药物传送结构，其特征在于，包括固定柱、若干个第一连接件和若干个第二连接件；
    所述第一连接件大体呈L型，所述第一连接件的短底面的两长侧边分别设有第一连接柱；
    所述第二连接件大体呈L型，所述第二连接件的短底面的两长侧边分别设有与该第一连接柱对应的第二连接柱；
    若干个所述第一连接柱与若干个所述第二连接柱两两扣合后，再通过所述固定柱固定连接形成所述药物传送结构。
  2. 根据权利要求1所述的药物传送结构，其特征在于，还包括第三连接件，所述第三连接件的两长侧边分别设置有所述第一连接柱和所述第二连接柱，所述第三连接件的第一连接柱与所述第二连接件的第二连接柱扣合再通过所述固定柱固定连接，所述第三连接件的第二连接柱与所述第一连接件的第一连接柱扣合再通过所述固定柱固定连接。
  3. 根据权利要求1所述的药物传送结构，其特征在于，所述第一连接柱包括间断设置的第一圆形连接柱和第一半圆形连接柱，所述第一圆形连接柱和所述第一半圆形连接柱在一条轴线上；所述第二连接柱包括间断设置的第二圆形连接柱和第二半圆形连接柱，所述第二圆形连接柱和所述第二半圆形连接柱在一条轴线上。
  4. 一种药物传送装置，其特征在于，包括上述权利要求1-3中任意一项所述的药物传送结构、用于提供驱动力的源驱动模块、主驱动模块及外壳；
    所述源驱动模块的驱动力传导给所述主驱动模块；所述主驱动模块用于驱动所述药物传送结构绕所述主驱动模块转动；所述药物传送结构转动的时候，带动置于所述药物传送结构中的药物运动；所述外壳用于收容所述源驱动模块、所述主驱动模块及所述药物传送结构；所述外壳还设有药物出口。
  5. 根据权利要求4所述的药物传送装置，其特征在于，所述源驱动模块包括电机和第一转轮，所述电机与所述第一转轮固定连接，所述电机转动的时候带动所述第一转轮转动。
  6. 根据权利要求4所述的药物传送装置，其特征在于，还包括分别连接所述源驱动模块与所述主驱动模块的传动模块；
    所述传动模块用于将所述源驱动模块的驱动力传导给所述主驱动模块；
    所述传动模块包括第二转轮，所述第二转轮与所述源驱动模块连接，所述源驱动模块转动时驱动所述第二转轮转动。
  7. 根据权利要求4所述的药物传送装置，其特征在于，所述主驱动模块包括第三转轮、第一转轴及第一链轮；
    所述第一转轴穿设于所述第一链轮中，所述第一转轴的一自由端与所述第三转轮的轴心固定连接，另一自由端收容于所述外壳中；所述第三转轮转动的时候带动所述第一转轴转动，进而带动所述第一链轮转动。
  8. 根据权利要求4所述的药物传送装置，其特征在于，还包括从驱动模块，所述从驱动模块与所述主驱动模块相对设置，使所述药物传送结构同时绕所述主驱动模块及所述从驱动模块转动；
    所述从驱动模块包括第二转轴及第二链轮；
    所述第二转轴穿设于所述第二链轮中，所述第二转轴的一自由端收容于所述外壳中，所述第二链轮转动的时候带动所述第二转轴转动。
  9. 根据权利要求4所述的药物传送装置，其特征在于，所述外壳包括收容槽与顶盖；所述收容槽用于收容所述源驱动模块、所述主驱动模块及所述药物传送结构，所述收容槽还设置有所述药物出口；所述 收容槽开口的一面与所述顶盖活动连接。
  10. 根据权利要求9所述的药物传送装置，其特征在于，还包括收容于所述收容槽的限位组件；
    所述药物传送结构围成一环形空间，所述限位组件安装于所述收容槽的内壁，并环绕所述环形空间延伸呈C形，所述限位组件两端之间形成的开口与上述药物出口相对设置；
    所述第一连接件的长底面与所述第二连接件的长底面于背离所述环形空间的一侧均设有避位切口，以在所述药物传送结构运动的过程中，避免所述第一连接件与所述限位组件干涉，以及避免所述第二连接件与所述限位组件干涉。
  11. 根据权利要求10所述的药物传送装置，其特征在于，所述收容槽包括底板以及自所述底板的边缘延伸形成的环形板，所述环形板的内壁设有至少一个沿第一方向延伸的限位槽，所述限位槽背离所述底板的一端贯通所述环形板；
    所述限位组件的边缘设有至少一组卡块，所述卡块的形状与所述限位槽相适配，一组卡块对应插入一所述限位槽，所述卡块与所述限位槽共同配合以对所述限位组件定位；
    其中，所述第一方向为所述底板指向所述环形板背离所述底板的一端的方向。
  12. 一种药柜，其特征在于，包括柜架与抽屉单元，所述柜架设有收纳空间，所述抽屉单元可于伸出位置与缩回位置之间滑动；
    于所述伸出位置，所述抽屉单元至少部分伸出所述收纳空间；
    于所述缩回位置，所述抽屉单元收容于所述收纳空间；
    其中，所述抽屉单元包括药物传送机构，所述药物传送机构包括如权利要求9至11中任一项所述的药物传送装置。
  13. 根据权利要求12所述的药柜，其特征在于，所述药物传送机构包括底座、连接组件以及所述药物传送装置，所述底座设有容纳槽，所述药物传送装置收容于所述容纳槽，所述连接组件包括：
    沿第一方向相对设置的两卡接件，所述卡接件安装于所述收容槽的外壁，并与所述收容槽之间沿所述第一方向滑动配合，所述卡接件可于锁止位置与解锁位置之间运动，所述卡接件背离另一所述卡接件的一侧设有卡接部，所述底座的内壁于对应所述卡接部处设有卡接槽；以及
    与所述卡接件一一对应的弹性件，所述弹性件设于两所述卡接件之间，所述弹性件的一端与所述卡接件抵接，另一端与所述收容槽抵接；
    于所述锁止位置，所述卡接部插入所述卡接槽；
    于所述解锁位置，所述卡接部退出所述卡接槽；
    其中，所述收容槽包括底板以及自所述底板的边缘延伸形成的环形板，所述第一方向为所述底板指向所述环形板背离所述底板的一端的方向。
  14. 根据权利要求13所述的药柜，其特征在于，所述收容槽沿所述第一方向相对的两表面分别向外延伸形成延伸板；
    所述卡接件包括基部与卡接部，所述基部背离另一所述卡接件的一侧设有所述卡接部；
    所述延伸板于对应所述卡接部处设有供所述卡接部穿过避让孔；
    于所述锁止位置，所述基部分别与所述弹性件及所述延伸板抵接，所述卡接部部分穿过所述避让孔。
  15. 根据权利要求13所述的药柜，其特征在于，所述底座于对应所述药物出口处设有贯通的药物通槽；
    所述药物传送机构还包括：
    闸门，安装于所述底座；以及
    驱动组件，安装于所述底座并与所述闸门连接，所述驱动组件用于驱动所述闸门于开门位置与关门位 置之间运动；
    于所述开门位置，所述闸门打开所述药物通槽；
    于所述关门位置，所述闸门关闭所述药物通槽。
  16. 根据权利要求12所述的药柜，其特征在于，所述药物传送机构还包括光电传感器；
    所述药物传送结构围成一环形空间，所述第一连接件或所述第二连接件于朝向所述环形空间的一面设有挡光片；
    所述光电传感器收容于所述环形空间，包括发射器与接收器，所述发射器与所述接收器第一方向间隔设置；
    所述挡光片用于在所述药物传送结构运动的过程中伸入所述发射器与所述接收器之间，以遮挡所述发射器，所述光电传感器用于在所述药物传送结构单向运动的过程中，测量所述发射器被所述挡光片遮挡的次数；
    其中，所述收容槽包括底板以及自所述底板的边缘延伸形成的环形板，所述第一方向为所述底板指向所述环形板背离所述底板的一端的方向。
  17. 根据权利要求16所述的药柜，其特征在于，所述药物传送机构还包括磁体、霍尔元件以及控制器；
    所述磁体设于所述药物传送结构，所述霍尔元件靠近所述药物传送结构设置，所述磁体与所述霍尔元件用于共同配合，以检测所述药物传送结构是否运动至预设位置；
    所述控制器分别与所述源驱动模块及所述霍尔元件连接；
    所述药物传送机构还包括收容于所述环形空间并与所述控制器连接的光电开关，所述光电开关包括光发射器与光接收器；
    各所述挡光片中的一个用于在所述磁体靠近所述霍尔元件的过程中，伸入所述光发射器与所述光接收器之间，以遮挡所述光发射器，进而使所述磁体、所述霍尔元件、所述挡光片及所述光电开关共同配合检测所述药物传送结构是否运动至预设位置。
  18. 根据权利要求12所述的药柜，其特征在于，所述抽屉单元包括：
    抽屉架，设有容置腔；
    输送机构，收容于所述容置腔，包括主动轮、从动轮、输送带以及动力组件，所述主动轮与从动轮均可转动地安装于所述抽屉架，且所述主动轮与所述从动轮沿第二方向间隔设置，所述输送带饶设于所述主动轮与所述从动轮，所述动力组件与所述主动轮连接，所述动力组件用于驱动所述主动轮转动；以及
    至少一药物传送机构组，所述药物传送机构组包括两药物传送机构，该两药物传送机构沿垂直于所述第二方向的方向分设于所述输送带的两侧，且该两药物传送机构的药物出口彼此面向设置；
    所述输送带用于接收所述药物传送机构送出的药品。
  19. 根据权利要求18所述的药柜，其特征在于，所述抽屉单元还包括承接台，所述承接台靠近所述从动轮设置，用于承接所述输送机构输送的药品；
    所述抽屉单元还包括与所述承接台一一对应的感应器，所述感应器与所述承接台连接，所述感应器用于检测所述承接台是否承接有药品。
PCT/CN2020/138847 2019-12-24 2020-12-24 药物传送结构、药物传送装置及药柜 WO2021129708A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201911347343.4A CN113023295B (zh) 2019-12-24 2019-12-24 药物传送结构及其装置
CN201911347343.4 2019-12-24

Publications (1)

Publication Number Publication Date
WO2021129708A1 true WO2021129708A1 (zh) 2021-07-01

Family

ID=76451750

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2020/138847 WO2021129708A1 (zh) 2019-12-24 2020-12-24 药物传送结构、药物传送装置及药柜

Country Status (2)

Country Link
CN (2) CN119873278A (zh)
WO (1) WO2021129708A1 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115326126A (zh) * 2022-08-19 2022-11-11 深圳诺博医疗科技有限公司 一种取药检测方法、取药检测装置和医疗设备

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003040003A1 (en) * 2001-11-08 2003-05-15 The Laitram Corporation Abrasion-resistant two-material hinge pin in a modular plastic conveyor belt
CN104797500A (zh) * 2012-08-31 2015-07-22 福尔康盛瑞士317有限公司 用于对配量的药品进行包装的设备以及用于运行该设备的方法
CN205873061U (zh) * 2016-07-29 2017-01-11 苏州信亨自动化科技有限公司 针对瓶装药剂的隔板式传送带发药机构
WO2017145315A1 (ja) * 2016-02-25 2017-08-31 株式会社アルス 搬送コンベヤ
CN109502238A (zh) * 2017-09-15 2019-03-22 莱德斯有限公司 具有接头铰链的用于传送化妆品容器的装置
CN110436035A (zh) * 2019-07-17 2019-11-12 宁波市北仑区人民医院 一种药品存储盒
CN212502582U (zh) * 2019-12-24 2021-02-09 深圳诺博医疗科技有限公司 药物传送结构及其装置

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5560473A (en) * 1994-11-07 1996-10-01 The Paxall Group, Inc. Drive mechanism for a carton conveyor
IT1305379B1 (it) * 1998-09-01 2001-05-04 Casmatic Spa Apparato per la regolazione automatica della lunghezza dei cassettidei trasportatori di macchine confezionatrici ed imballatrici
DE60039819D1 (de) * 1999-07-02 2008-09-25 Tissue Machinery Co S P A Verpackungsmaschine für Produkte mit Schnelleinstellsystem zur Umstellung auf Produkte anderer Abmessungen
ITBO20000685A1 (it) * 2000-11-23 2002-05-23 Gianluigi Gamberini Dispositivo di traino per macchine per il confezionamento di articoliin rotoli e simili
ITBO20050773A1 (it) * 2005-12-20 2007-06-21 Tissue Machinery Co Spa Macchina per la produzione di gruppi di prodotti in rotolo
CN104044853B (zh) * 2014-05-29 2016-09-14 深圳市瑞驰智能系统有限公司 一种针剂药盒及其针剂发药机
CN208413012U (zh) * 2018-07-16 2019-01-22 红塔烟草(集团)有限责任公司 一种输送链条自动张紧装置

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003040003A1 (en) * 2001-11-08 2003-05-15 The Laitram Corporation Abrasion-resistant two-material hinge pin in a modular plastic conveyor belt
CN104797500A (zh) * 2012-08-31 2015-07-22 福尔康盛瑞士317有限公司 用于对配量的药品进行包装的设备以及用于运行该设备的方法
WO2017145315A1 (ja) * 2016-02-25 2017-08-31 株式会社アルス 搬送コンベヤ
CN205873061U (zh) * 2016-07-29 2017-01-11 苏州信亨自动化科技有限公司 针对瓶装药剂的隔板式传送带发药机构
CN109502238A (zh) * 2017-09-15 2019-03-22 莱德斯有限公司 具有接头铰链的用于传送化妆品容器的装置
CN110436035A (zh) * 2019-07-17 2019-11-12 宁波市北仑区人民医院 一种药品存储盒
CN212502582U (zh) * 2019-12-24 2021-02-09 深圳诺博医疗科技有限公司 药物传送结构及其装置

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115326126A (zh) * 2022-08-19 2022-11-11 深圳诺博医疗科技有限公司 一种取药检测方法、取药检测装置和医疗设备

Also Published As

Publication number Publication date
CN119873278A (zh) 2025-04-25
CN113023295B (zh) 2025-03-21
CN113023295A (zh) 2021-06-25

Similar Documents

Publication Publication Date Title
JP7009584B2 (ja) 単位用量ディスペンスシステムおよび方法
KR102557367B1 (ko) 단위 투약 분배 장치
EP3300044B1 (en) Medicine-dispensing apparatus
WO2021129708A1 (zh) 药物传送结构、药物传送装置及药柜
US20140103061A1 (en) Dispensing box for drug-containing ampoule
KR102083863B1 (ko) 약제 충전 장치
CN212502582U (zh) 药物传送结构及其装置
CN214933184U (zh) 药物传送机构与药柜
CN107161671B (zh) 一种针剂瓶的自动发放装置
JP7342262B2 (ja) 予め充填された注射器用の払出システムおよび方法
US10445970B2 (en) Medicine-dispensing apparatus
CN214933250U (zh) 药物传送装置与药柜
ES2775225T3 (es) Caja dispensadora para ampolla contenedora de medicamento

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20905973

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205 DATED 17.08.2022)

122 Ep: pct application non-entry in european phase

Ref document number: 20905973

Country of ref document: EP

Kind code of ref document: A1